Paul Terasaki

Q: What Schools Are Affiliated With Paul Terasaki

Paul Terasaki is affiliated with the following schools: Wayne State University, University of California, Los Angeles, University of California, San Francisco

Paul Terasaki's AcademicInfluence.com Rankings

Paul Terasaki

Philosophy

#1615

World Rank

#2892

Historical Rank

#635

USA Rank

Logic

#265

World Rank

#548

Historical Rank

#114

USA Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Paul Terasaki Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Paul Ichiro Terasaki was an American scientist in the field of human organ transplant technology, and professor emeritus of surgery at UCLA School of Medicine. He spent three high school years during World War II interned with his family and other Japanese Americans in the Gila River War Relocation Center. Later he earned his bachelor's, master's, and doctorate in zoology all from UCLA and was appointed to the medical school faculty.

(See a Problem?)

Paul Terasaki's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Nomenclature for factors of the HLA system, 2010 (2010) (2496)
Microdroplet Assay of Human Serum Cytotoxins (1964) (2054)
Significance of the positive crossmatch test in kidney transplantation. (1969) (1339)
Effect of pravastatin on outcomes after cardiac transplantation. (1995) (1309)
High association of an HL-A antigen, W27, with ankylosing spondylitis. (1973) (1252)
High survival rates of kidney transplants from spousal and living unrelated donors. (1995) (1240)
SEROTYPING FOR HOMOTRANSPLANTATION XVIII. REFINEMENT OF MICRODROPLET LYMPHOCYTE CYTOTOXICITY TEST (1968) (1069)
Effect of blood transfusions on subsequent kidney transplants. (1973) (981)
Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. (1978) (949)
HLA and Disease Associations (1985) (590)
Long-term survival. (1988) (499)
Characterization of sialosylated Lewisx as a new tumor-associated antigen. (1984) (484)
KIDNEY PRESERVATION FOR TRANSPORTATION: Initial Perfusion and 30 Hours' Ice Storage (1969) (463)
Predicting Kidney Graft Failure by HLA Antibodies: a Prospective Trial (2004) (438)
Nomenclature for factors of the HLA system, 2004 (2005) (431)
Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities (2003) (398)
Improvement of kidney-graft survival with increased numbers of blood transfusions. (1978) (396)
Anti-HLA antibodies after solid organ transplantation. (2000) (389)
Reactivity of lymphocytes from normal persons on cultured tumor cells. (1973) (382)
Humoral Theory of Transplantation (2003) (358)
Four‐year Follow‐up of a Prospective Trial of HLA and MICA Antibodies on Kidney Graft Survival (2007) (356)
Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts (2009) (343)
Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts (2013) (341)
CHIMERISM AND DONOR‐SPECIFIC NONREACTIVITY 27 TO 29 YEARS AFTER KIDNEY ALLOTRANSPLANTATION (1993) (337)
All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies (2002) (323)
Cytotoxins in disease. Autocytotoxins in lupus. (1970) (317)
Serotyping for Homotransplantation (1968) (316)
Multiple sclerosis: association with HL-A3. (2008) (300)
Liver transplantation in the United States. (2005) (295)
Autologous stimulation of human lymphocyte subpopulation (1975) (286)
Transplantation of kidneys from donors whose hearts have stopped beating. (1998) (285)
“Natural” Human Leukocyte Antigen Antibodies Found in Nonalloimmunized Healthy Males (2008) (285)
Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. (2005) (280)
Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. (1988) (279)
Deliberate Donor‐specific Blood Transfusions Prior to Living Related Renal Transplantation: A New Approach (1980) (264)
The hyperfiltration hypothesis in human renal transplantation. (1994) (262)
Nomenclature for Factors of the HLA System, 1995 (1995) (262)
Nomenclature for Factors of the HLA System, 1991 (1992) (259)
De Novo Donor HLA‐Specific Antibodies after Heart Transplantation Are an Independent Predictor of Poor Patient Survival (2011) (252)
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. (1993) (246)
Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. (2000) (244)
Nomenclature for factors of the HLA system, 1996. (1997) (244)
The use of cyclosporin A and prednisone in cadaver kidney transplantation. (1980) (236)
Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. (1970) (235)
Human Leukocyte Antigen Antibodies and Chronic Rejection: From Association to Causation (2008) (227)
Extremely High Association Between Appearance of HLA Antibodies and Failure of Kidney Grafts in a Five‐Year Longitudinal Study (2007) (226)
Nomenclature for factors of the HLA system, 2002. (2002) (220)
De Novo Donor‐Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients (2013) (219)
Serial Ten‐Year Follow‐Up of HLA and MICA Antibody Production Prior to Kidney Graft Failure (2005) (218)
Nomenclature for Factors of the HLA System, 1994 (1994) (214)
Disturbance of HL-A antigen frequency in Psoriasis. (1972) (208)
Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. I. Detection by rabbit antisera (1976) (202)
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome. (2002) (202)
Significance of the donor age effect on kidney transplants. (1997) (198)
Nomenclature for Factors of the HLA System, 2004. (2005) (194)
Humoral theory of transplantation: further evidence. (2005) (193)
Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. (1992) (189)
[Microdroplet lymphocyte cytotoxicity test]. (1973) (188)
Shwartzman reaction after human renal homotransplantation. (1968) (187)
Higher Risk of Kidney Graft Failure in the Presence of Anti‐Angiotensin II Type‐1 Receptor Antibodies (2013) (181)
The Role of Donor‐Specific HLA Alloantibodies in Liver Transplantation (2014) (173)
Presensitization and kidney transplant failures (1971) (172)
HLA-Specific Antibodies Developed in the First Year Posttransplant are Predictive of Chronic Rejection and Renal Graft Loss (2009) (168)
The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes (2013) (165)
Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. (1974) (164)
ANALYSES OF THE UNOS SCIENTIFIC RENAL TRANSPLANT REGISTRY AT THREE YEARS—EARLY EVENTS AFFECTING TRANSPLANT SUCCESS1–3 (1992) (164)
Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. (1977) (163)
Predictive Value of HLA Antibodies and Serum Creatinine in Chronic Rejection: Results of a 2-year Prospective Trial (2005) (161)
Nomenclature for Factors of the HLA System, 1998 (1999) (160)
A new microcellular cytotoxicity test based on calcein AM release. (1993) (159)
SEROTYPING FOR HOMOTRANSPLANTATION. X. SURVIVAL OF 196 GRAFTED KIDNEYS SUBSEQUENT TO TYPING (1967) (158)
Dominant effect of transfusions on kidney graft survival. (1980) (157)
High Mean Fluorescence Intensity Donor‐Specific Anti‐HLA Antibodies Associated With Chronic Rejection Postliver Transplant (2011) (155)
The beneficial transfusion effect on kidney graft survival attributed to clonal deletion. (1984) (153)
Nomenclature for factors of the HLA system, 1998. (1999) (152)
Sjögren's Syndrome Associated with HLA-Dw3 (1977) (152)
Human renal transplants. I. Glomerular changes. (1967) (149)
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. (1995) (148)
Flow cytometric detection of HLA antibodies using a spectrum of microbeads. (1999) (146)
Nomenclature for factors of the HLA system, 2000. (2001) (145)
Induction Immunosuppression Improves Long-Term Graft and Patient Outcome in Organ Transplantation: An Analysis of United Network for Organ Sharing Registry Data (2010) (140)
Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). (1970) (140)
The Importance of Anti‐HLA‐Specific Antibody Strength in Monitoring Kidney Transplant Patients (2007) (138)
HLA antibody identification with single antigen beads compared to conventional methods. (2005) (135)
Use of monoclonal antibodies to sialylated Lewisx and sialylated Lewisa for serological tests of cancer. (1985) (132)
THE SIGNIFICANCE OF A POSITIVE FLOW CYTOMETRY CROSSHATCH TEST IN PRIMARY KIDNEY TRANSPLANTATION (1993) (130)
Association of primary sclerosing cholangitis with HLA-DRw52a. (1990) (130)
Epitopes of human leukocyte antigen class I antibodies found in sera of normal healthy males and cord blood. (2009) (128)
Abrogation of Anti-HLA Antibodies via Proteasome Inhibition (2009) (128)
Direct blood group typing of forensic samples using a simple monoclonal antibody assay. (1987) (127)
MATERNAL-FETAL INCOMPATIBILITY: Incidence of HL-A Antibodies and Possible Association with Congenital Anomalies (1970) (126)
HL-A W27--a clue to the diagnosis and pathogenesis of Reiter's syndrome. (1974) (125)
Studies on specificity of cell-mediated immunity to human tumors. (1974) (124)
Cross-Reactions between Streptococcal M Proteins and Human Transplantation Antigens (1970) (124)
Donor‐specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with Chronic rejection and graft loss after liver transplantation (2012) (124)
Impact of IgG3 Subclass and C1q‐Fixing Donor‐Specific HLA Alloantibodies on Rejection and Survival in Liver Transplantation (2015) (123)
The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro. (1998) (122)
Soluble HLA‐G Expression and Renal Graft Acceptance (2006) (120)
Selecting donors of platelets for refractory patientson the basis of HLA antibody specificity (2000) (119)
Multiple sclerosis and high incidence of a B lymphocyte antigen. (1976) (113)
Humoral theory of transplantation: mechanism, prevention, and treatment. (2005) (112)
Pediatric renal transplantation: a review of the UNOS data. United Network for Organ Sharing. (1997) (112)
HLA-DRW4 IN 91% OF JEWISH PEMPHIGUS VULGARIS PATIENTS (1979) (109)
Preformed class II donor‐specific antibodies are associated with an increased risk of early rejection after liver transplantation (2013) (108)
Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching. (1969) (106)
Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients. (1981) (106)
Nomenclature for factors of the HLA system, 1987. (1988) (106)
INDUCTION OF HIGH KIDNEY GRAFT SURVIVAL RATE BY MULTIPLE TRANSFUSION (1981) (106)
HLA Genotypic Study of Insulin-dependent Diabetes: The Excess of DR3/DR4 Heterozygotes Allows Rejection of the Recessive Hypothesis (1983) (106)
The Data and Statistical Analysis (1985) (105)
Analysis of HL-A incompatibility in human renal transplants. (2008) (104)
Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California. (1995) (102)
A SEMIMICRO MIXED LEUKOCYTE CULTURE TEST (1971) (100)
Suppression of transfusion-related alloimmunization in intensively treated cancer patients. (1981) (98)
Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes (2013) (98)
Antibody‐mediated rejection as a contributor to previously unexplained early liver allograft loss (2014) (93)
Identification of unresponsive kidney-transplant recipients. (1972) (93)
The UNOS Scientific Renal Transplant Registry. (1993) (92)
HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens. (2007) (91)
Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival. (1994) (90)
HLA determinants in chronic active liver disease: possible relation of HLA-Dw3 to prognosis. (2008) (90)
Abnormalities in thyroid function in relatives of patients with Graves' disease and Hashimoto's thyroiditis: lack of correlation with inheritance of HLA-B8. (1977) (90)
PROLONGATION EFFECT OF BLOOD TRANSFUSIONS ON KIDNEY GRAFT SURVIVAL (1976) (88)
Intact HLA Not &bgr;2m-free Heavy Chain-Specific HLA Class I Antibodies Are Predictive of Graft Failure (2009) (87)
HLA-B15: a widespread and diverse family of HLA-B alleles. (1994) (87)
Proposed Diagnostic Criteria for Chronic Antibody‐Mediated Rejection in Liver Allografts (2016) (87)
Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin. (1996) (87)
Increased prevalence of W27 in juvenile rheumatoid arthritis. (1974) (85)
The UNOS Scientific Renal Transplant Registry. (1989) (85)
Lung transplantation in the United States: 1990-2005. (2005) (85)
Nomenclature for factors of the HLA system, 1991 (1992) (85)
SEROTYPING FOR HOMOTRANSPLANTATION: XII. OCCURRENCE OF CYTOTOXIC ANTIBODIES FOLLOWING KIDNEY TRANSPLANTATION IN MAN (1968) (85)
ADVANTAGE OF COLD STORAGE OVER MACHINE PERFUSION FOR PRESERVATION OF CADAVER KIDNEYS (1982) (82)
HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. (1976) (82)
Frequency of MIC antibody in rejected renal transplant patients without HLA antibody. (2006) (81)
Gene Mapping in the Idiopathic Generalized Epilepsies: Juvenile Myoclonic Epilepsy, Childhood Absence Epilepsy, Epilepsy with Grand Mai Seizures, and Early Childhood Myoclonic Epilepsy (1990) (81)
HIV-Positive Renal Recipients Can Achieve Survival Rates Similar to Those of HIV-Negative Patients (2006) (80)
An analysis of the OPTN/UNOS Liver Transplant Registry. (2004) (79)
Human renal transplants (1967) (78)
Genetic susceptibility to multiple sclerosis (1979) (77)
Association of kidney transplant failure and antibodies against MICA. (2006) (77)
Spousal and other living renal donor transplants. (1997) (77)
No Improvement in Long‐Term Liver Transplant Graft Survival in the Last Decade: An Analysis of the UNOS Data (2006) (77)
Human Leukocyte Antigen Class I Epitopes: Update to 103 Total Epitopes, Including the C Locus (2007) (75)
HL-A AND KIDNEY TRANSPLANTS: REEXAMINATION (1974) (75)
National allocation of cadaveric kidneys by HLA matching. Projected effect on outcome and costs. (1991) (75)
Mapping the Gene for Juvenile Myoclonic Epilepsy (1989) (74)
Nomenclature for Factors of the HLA System, 1990 (1991) (74)
Flow cytometry crossmatching in human cadaver kidney transplantation. (1987) (73)
A personal perspective: 100-year history of the humoral theory of transplantation. (2012) (73)
Histocompatibility (HL-A) antigens and lymphocytotoxic antibodies in systemic lupus erythematosus (SLE). (1974) (72)
HL-A-W27--a useful discriminator in the arthropathies of inflammatory bowel disease. (1974) (72)
Development of Nondonor‐Specific HLA‐DR Antibodies in Allograft Recipients Is Associated with Shared Epitopes with Mismatched Donor DR Antigens (2006) (72)
Equitable allocation of HLA-compatible kidneys for local pools and for minorities. (1994) (71)
Report on the second new world B-cell workshop. (1977) (71)
Association of Anti-Human Leukocyte Antigen and Anti-Angiotensin II Type 1 Receptor Antibodies With Liver Allograft Fibrosis After Immunosuppression Withdrawal (2014) (71)
Acute liver allograft antibody‐mediated rejection: An inter‐institutional study of significant histopathological features (2014) (70)
Cadaver-kidney transplant failures at one month. (1974) (70)
HL-A antigens in solid tumors. (1973) (70)
Autoimmune Thyroid Diseases—Graves' and Hashimoto's (1978) (70)
Nomenclature for Factors of the HLA System, 1996 (1997) (69)
Evidence for immunosuppression by high-dose gammaglobulin. (1987) (69)
SUCCESSFUL RENAL ALLOGRAFTS ACROSS A POSITIVE CROSS-MATCH FOR DONOR B-LYMPHOCYTE ALLOANTIGENS (1976) (69)
Suppression of lymphocyte transformation by aspirin. (1973) (69)
DOMINANT EFFECT OF HISTOCOMPATIBILITY ON TEN‐YEAR KIDNEY TRANSPLANT SURVIVAL (1988) (68)
Increased frequency of HL-A10 in pemphigus vulgaris. (1973) (66)
HLA MATCHING AND CADAVER KIDNEY TRANSPLANT SURVIVAL IN NORTH AMERICA: INFLUENCE OF CENTER VARIATION AND PRESENSITIZATION (1977) (66)
Cross-reactivity in the HL-A system. (2008) (66)
Detection of antibodies to HLA-DP in renal transplant recipients using single antigen beads. (2005) (66)
Calculations on long-term graft and patient survival in human kidney transplantation. (1977) (66)
The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats. (1990) (66)
Impact of IgM and IgG3 Anti-HLA Alloantibodies in Primary Renal Allograft Recipients (2014) (65)
Fit and match hypothesis for kidney transplantation. (1996) (64)
HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. (1980) (63)
HLA antigens associated with systemic lupus erythematosus in Japan. (1985) (63)
Deduction of the fraction of immunologic and non-immunologic failure in cadaver donor transplants. (2003) (63)
HLA matching: identification of permissible HLA mismatches. (1993) (62)
Association of Sjögren's syndrome with HLA-B8. (1976) (62)
Defective T cell function in atopic dermatitis. (1976) (61)
Natural and acquired epidermal autoantibodies in man. (1974) (60)
Hyperacute rejection of a transplanted human heart. (1981) (60)
B-lymphocyte alloantigens in Caucasians (1976) (59)
Serotyping for homotransplantation XVI (1969) (59)
MULTIVARIATE ANALYSIS OF RISK FACTORS IMPACTING ON IMMEDIATE AND EVENTUAL CADAVER ALLOGRAFT SURVIVAL IN CYCLOSPORINE‐TREATED RECIPIENTS (1987) (59)
ABO incompatibility in cadaver donor kidney allografts. (1987) (58)
HL‐A Haplotypes of 32 Diseases (1975) (58)
SEROTYPING FOR HOMOTRANSPLANTATION: XXIII. Analysis of Kidney Transplants from Parental versus Sibling Donors (1969) (58)
Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker (1977) (58)
Beyond Histology: Lowering Human Leukocyte Antigen Antibody to Improve Renal Allograft Survival in Acute Rejection (2010) (58)
Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27. (1974) (57)
Thirty year trend in kidney transplants: UCLA and UNOS Renal Transplant Registry. (2006) (57)
Historic Landmarks in Clinical Transplantation: Conclusions from the Consensus Conference at the University of California, Los Angeles (2000) (57)
Leukocyte transfusions: role of leukocyte alloantibodies in determining transfusion response. (1971) (56)
The clinical impact of humoral immunity in pediatric renal transplantation. (2013) (56)
PUBLIC DETERMINANTS OF HLA INDICATED BY PREGNANCY ANTIBODIES (1986) (56)
SEROTYPING FOR HOMOTRANSPLANTATION V. EVALUATION OF A MATCHING SCHEME (1966) (56)
CYTOTOXINS IN DISEASE: III. Antibodies Against Lymphocytes Produced By Vaccination (1970) (55)
Nomenclature for factors of the HLA system, 1991 (1992) (55)
Relationship of Hla‐Dw3 and Hla‐B8 to Sjögren'S Syndrome (1978) (55)
HLA and cross-reactive antigen group matching for cadaver kidney allocation. (1997) (55)
Strategy for eliminating the kidney shortage. (1997) (54)
HUMAN BLOOD LYMPHOCTYE CYTOTOXICITY REACTIONS WITH ALLOGENIC ANTISERA * (1964) (54)
Repeating HLA antigen mismatches in renal retransplants--a second class mistake? (1994) (54)
INTERNATIONAL STUDY OF HISTOCOMPATIBILITY IN RENAL TRANSPLANTATION (1982) (54)
Antibodies to HLA-E in Nonalloimmunized Males: Pattern of HLA-Ia Reactivity of Anti–HLA-E–Positive Sera (2010) (54)
History of Transplantation: Thirty-Five Recollections (1991) (54)
Lymphocyte Antigenicity Loss with Retention of Responsiveness (1974) (53)
Donor‐specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus–infected patients (2014) (52)
Lymphocytotoxic definition of combined ABH and Lewis antigens and their transfer from sera to lymphocytes. (1980) (51)
Correlation Between Human Leukocyte Antigen Antibody Production and Serum Creatinine in Patients Receiving Sirolimus Monotherapy after Campath-1H Induction (2004) (51)
Leukocyte Transfusions (1971) (51)
Influence of race on kidney transplant survival. (1977) (51)
Phytohemagglutinin (PHA) skin test in the diagnosis of cellular immunodeficiency. (1973) (50)
Clinical kidney transplants. (1981) (49)
Paired kidney exchange is not a solution to ABO incompatibility. (1998) (49)
HLA phenotype frequencies in individuals with cleft lip and/or cleft palate. (1978) (49)
Autolymphocytotoxins following immunization by pregnancy, transplantation, and disease. (2008) (49)
Analysis of HLA Class I Specific Antibodies in Patients with Failed Allografts (2007) (49)
SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY‐TWO RECIPIENTS * (1966) (49)
Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies. (2002) (48)
Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens. (2009) (48)
Recombination within the HL-A locus. (2008) (48)
Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients (2017) (48)
Identification of the type of blood-cell responsible for the graft-versus-host reaction in chicks. (1959) (47)
Genetic epidemiology of breast cancer and associated cancers in high-risk families. II. Linkage analysis. (1983) (47)
CROSS REACTIONS BETWEEN HUMAN TRANSPLANTATION ANTIGENS AND BACTERIAL LIPOPOLYSACCHARIDES1 (1973) (47)
Antibody mediated rejection: update 2006. (2006) (47)
Association between HL-A2 antigen and various periodontal diseases in young adults. (1975) (47)
AUTOANTIBODY AGAINST B LYMPHOCYTES (1977) (46)
The UNOS scientific renal transplant registry. United Network for Organ Sharing. (1995) (46)
Low HL—A2 Frequency and Periodontitis1 (1975) (46)
Nomenclature for factors of the HLA system, 2002. (2002) (46)
BLOOD TRANSFUSIONS AND UNRESPONSIVENESS TO HL‐A (1973) (46)
Nomenclature for factors of the HLA System, 1996. (1997) (46)
Post-transplantation antibody monitoring and HLA antibody epitope identification. (2008) (45)
Longitudinal testing of 266 renal allograft patients for HLA and MICA antibodies: Greenville experience. (2006) (45)
Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1). (1980) (45)
SEROTYPING FOR HOMOTRANSPLANTATION XVII. PRELIMINARY STUDIES OF HL‐A SUBUNITS AND ALLELES (1968) (45)
Human leukocyte antigen crossmatch testing is important for liver retransplantation (2010) (45)
The association of HLA antigens A3, B7, and DW2 with 330 multiple sclerosis patients in the United States. (2008) (45)
Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up. (2006) (44)
INCREASED FREQUENCY OF HLA-DRW2 IN SLE (1979) (44)
14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project. (2007) (44)
Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants. (1980) (44)
An update to HLA Nomenclature, 2010 (2010) (44)
PREDICTION OF LONG‐TERM KIDNEY TRANSPLANT SURVIVAL RATES BY MONITORING EARLY GRAFT FUNCTION AND CLINICAL GRADES (1978) (44)
Serotyping for Homotransplantation. XXII, Specificity of Cytotoxic Antibodies Developing after Renal Transplantation (1969) (44)
THE ROLE OF IgA ANTI‐HLA CLASS I ANTIBODIES IN KIDNEY TRANSPLANT SURVIVAL (1993) (44)
Thoracic Duct Fistula and Renal Transplantation (1979) (43)
Successful transplants across T warm-positive crossmatches due to IgM ANTIBODIES (1988) (43)
Risk rate and long-term kidney transplant survival. (1996) (43)
Sensitization to human lymphocyte antigens by corneal transplantation. (1973) (43)
Human Leukocyte Antigen Class II DQ Alpha and Beta Epitopes Identified From Sera of Kidney Allograft Recipients (2008) (43)
Blood transfusions and kidney transplants: remaining controversies. (1981) (43)
Patient death after renal transplantation--an analysis of its role in graft outcome. (1996) (42)
A ten-year prediction for kidney transplant survival. (1992) (42)
Histocompatibility testing for leucocyte transfusion. (1970) (42)
Escape from sensitization to HL-A antibodies. (2008) (42)
Calculation of probability of paternity using DNA sequences. (1988) (41)
HL-A W27 in psoriatic arthropathy. (1975) (41)
Therapeutic preparations of IVIg contain naturally occurring anti-HLA-E antibodies that react with HLA-Ia (HLA-A/-B/-Cw) alleles. (2013) (41)
HLA-DR specificities among Japanese with several autoimmune diseases. (1982) (41)
HLA-B5 associated with duodenal ulcer. (1977) (41)
Case-control study of Hodgkin's disease. II. Herpesvirus group antibody titers and HL-A type. (1973) (41)
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. (1968) (41)
Comprehensive Method for the Typing of HLA‐A, B, and C Alleles by Direct Sequencing of PCR Products Obtained from Genomic DNA (1997) (41)
Destruction of lymphocytes in vitro by normal serum from common laboratory animals. (1961) (41)
Leucocyte Antigens and Disease: 1. Association of HL-A2 and Chronic Glomerulonephritis (1969) (40)
Optimal use for older donor kidneys: older recipients. (1995) (40)
Twenty-year follow-up on the effect of HLA matching on kidney transplant survival and prediction of future twenty-year survival. (1996) (40)
Durability of Antibody Removal Following Proteasome Inhibitor-Based Therapy (2012) (40)
Shwartzman reaction after human renal transplantation (1968) (40)
High one-month liver graft failure rates in flow cytometry crossmatch-positive recipients. (1994) (39)
Depressed lymphocyte-mediated killing of sensitized targets in cancer patients. (1974) (39)
HLA-E monoclonal antibodies recognize shared peptide sequences on classical HLA class Ia: relevance to human natural HLA antibodies. (2010) (39)
Association of HLA antigen a9 with progressive systemic sclerosis (scleroderma). (1978) (39)
Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation. (2013) (38)
NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1995 (1995) (38)
A search for heterogeneity in insulin dependent diabetes mellitus (IDDM): HLA and autoimmune studies in simplex, multiplex and multigenerational families. (1983) (38)
ENHANCEMENT OF HUMAN KIDNEY ALLOGRAFTS BY COLD B-LYMPHOCYTE CYTOTOXINS (1978) (38)
Evaluation of Belzer and Collins kidney-preservation methods. (1973) (38)
Using Donor-Specific Antibodies to Monitor the Need for Immunosuppression (2012) (38)
Serotyping for homotransplantation. XX. Selection of recipients for cadaver donor transplants. (1968) (38)
Long-term survival of kidney grafts. (1989) (37)
Insights into the expression of ABH and Lewis antigens through human bone marrow transplantation. (1981) (37)
Cytomegalovirus antibody status and renal transplantation: 1987-1994. (1996) (37)
Absence of immunization effect in human-kidney retransplantation. (1978) (37)
Protective Immunity Remains Intact After Antibody Removal by Means of Proteasome Inhibition (2010) (37)
Pretreatment with donor-specific blood transfusions in related recipients with high MLC. (1981) (37)
B cell antibodies and crossmatching. (1980) (37)
Epitopes of the HLA-A, B, C, DR, DQ and MICA antigens. (2007) (37)
HLA-DRW4 antigen linkage in patients with hypertrophic obstructive cardiomyopathy. (1981) (37)
IN VITRO STUDIES TO EXPLAIN HIGH RENAL ALLOGRAFT SURVIVAL IN IGA NEPHROPATHY PATIENTS (1993) (37)
Non-HLA lymphocyte cytotoxins in various diseases. (2008) (36)
Do prophylactic antilymphocyte globulins (ALG and OKT3) improve renal transplant survival in recipient and donor high-risk groups? (1993) (36)
Autotransplantation after in vitro immunotherapy of lymphoblastic leukemia. (1979) (36)
Tumour regression following stem cell infusion from daughter to microchimeric mother (2001) (36)
A RAPID METABOLISM TEST TO SCREEN CADAVER KIDNEYS FOR TRANSPLANTATION (1967) (36)
Kidney preservation for transplantation. I. Twelve-hour storage in rabbits. (1969) (36)
HLA antigens in recurrent stromal herpes simplex virus keratitis. (1980) (36)
Clonal deletion with bortezomib followed by low or no maintenance immunosuppression in renal allograft recipients. (2010) (35)
Thoracic duct drainage before and after cadaveric kidney transplantation. (1979) (35)
Nomenclature for Factors of the HLA System, 1998 (1999) (35)
ABO incompatible kidney transplantation – an analysis of UNOS Registry data (2006) (35)
Genetic factors in Haemophilus influenzae type b disease susceptibility and antibody acquisition. (1987) (35)
In vitro immunization to cultured human tumor cells. (1974) (35)
THE LARGE CENTER VARIATION IN HALF‐LIVES OF KIDNEY TRANSPLANTS 1,2,3 (1992) (34)
Chronic renal homograft function: correlation with histology and lymphocyte antigen matching. (1967) (34)
Anti-HLA-B7,B27,Bw42,Bw54,Bw55,Bw56, Bw67,Bw73 monoclonal antibodies: specificity, idiotypes, and application for a double determinant immunoassay. (1988) (34)
Histocompatibility antigens in patients with leprosy. (1976) (34)
Brief Communication: HL-A Heterozygosity as a Genetic Marker of Long-Term Survival (1974) (34)
Early graft function. (1987) (34)
Sialosylated Lewisx in the sera of cancer patients detected by a cell-binding inhibition assay. (1985) (34)
The HLA-matching effect in different cohorts of kidney transplant recipients. (2000) (33)
Histocompatibility matching utilizing responsiveness as a new dimension. (1972) (33)
Twins with Two Different Fathers Identified by HLA (1978) (33)
THE EFFECT OF ZERO HLA CLASS I AND II MISMATCHING IN CYCLOSPORINE‐TREATED KIDNEY TRANSPLANT PATIENTS (1987) (33)
Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies. (2011) (33)
HL-A leukocyte antigen studies in women with gestational trophoblastic neoplasms. (1971) (33)
Outcome of kidney transplants and suppression of mixed leukocyte culture by plasma. (1973) (33)
HLA class II DQA and DQB epitopes: recognition of the likely binding sites of HLA-DQ alloantibodies eluted from recombinant HLA-DQ single antigen cell lines. (2013) (33)
SIALYLATED LEWISx ANTIGEN DETECTED IN THE SERA OF CANCER PATIENTS (1984) (33)
Monitoring and treating posttransplant human leukocyte antigen antibodies. (2009) (33)
COMPARISON OF KIDNEY TRANSPLANT SURVIVAL AMONG TRANSPLANT CENTERS (1975) (32)
HLA-DR Specifications in Japanese with Juvenile-onset Insulin-Dependent Diabetes Mellitus (1982) (32)
Induction of CD4+ cytotoxic T cells by sensitization with allogeneic melanomas bearing shared or cross-reactive HLA-A. (1992) (32)
Human histocompatibility antigens of leukocytes. (1969) (32)
Detection of sialylated lewisX antigen in cancer sera using a sandwich radioimmunoassay (1985) (32)
Elimination of post-transplant donor-specific HLA antibodies with bortezomib. (2008) (31)
Levamisole-associated neutropenia and autoimmune granulocytotoxins. (1980) (31)
Familial Mediterranean fever. Recent advances in pathogenesis and management. (1977) (31)
Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients. (1998) (31)
Anti-tumor necrosis factor antibody enhances allograft survival in rats. (1990) (31)
Association of emergence of HLA antibody and acute rejection in intestinal transplant recipients: a possible evidence of acute humoral sensitization. (2006) (31)
BONE MARROW TRANSPLANTATION FROM HL‐A‐MATCHED DONORS TO PATIENTS WITH ACUTE LEUKEMIA TOXICITY AND ANTILEUKEMIC EFFECT (1972) (31)
A single mutation hypothesis for multiple sclerosis based on the HL‐A system (1976) (31)
Antibody response to homografts. VIII. Relation of mouse hemagglutinins and cytotoxins. (1963) (31)
INFLUENCE OF SEX ON HISTOCOMPATIBILITY MATCHING IN RENAL TRANSPLANTATION (1977) (31)
Summary of the effect of de novo HLA antibodies on chronic kidney graft failure. (2006) (31)
Conformational Variants of the Individual HLA-I Antigens on Luminex Single Antigen Beads Used in Monitoring HLA Antibodies: Problems and Solutions (2017) (31)
Studies on the strength of HLA antigens in related donor kidney transplants. (1977) (31)
GRAFTING OF FETAL THYMUS AND HEMATOPOIETIC TISSUE IN INFANTS WITH IMMUNE DEFICIENCY SYNDROMES1 (1973) (30)
Pretreatment of cadaver donors with methylprednisolone in human renal allografts. (1977) (30)
Anti-B lymphocytotoxins in renal-allograft rejection. (1976) (30)
Histocompatibility antigens in a genetically isolated American indian tribe. (1973) (30)
Antibody-dependent lymphocyte killer function and age. (1973) (30)
Vertebral ankylosing hyperostosis (Forestier's disease) and HLA antigens in Pima Indians. (1978) (30)
FACTORS INFLUENCING THE PARADOXICAL EFFECT OF TRANSFUSIONS ON KIDNEY TRANSPLANTS (1983) (30)
The transfusion effect. (1988) (30)
Serological cross-reactivity in the HL-A system. (2008) (29)
SIGNIFICANCE OF MIXED LEUKOCYTE CULTURE TESTING IN CADAVER KIDNEY TRANSPLANTATION (1977) (29)
Fifteen-year kidney graft survival. (1989) (29)
HISTOCOMPATIBILITY ANTIGENS IN AMYOTROPHIC LATERAL SCLEROSIS AND PARKINSONISM-DEMENTIA ON GUAM (1977) (29)
The flow cytometry crossmatch in kidney transplantation. (1987) (29)
Evidence for a second B-cell locus separate from the DR locus. (1978) (29)
Genetics of four new HL-A specificities in the Caucasian and Negro populations. (1971) (28)
The impact of T-cell depletion on the effects of HLA DRβ1 and DQβ allele matching in HLA serologically identical unrelated donor bone marrow transplantation (1997) (28)
Mechanisms of HLA and Disease Associations (1985) (28)
Incidence, characteristics, and outcome of recipients sensitized after donor-specific blood transfusions. (1981) (28)
SEROTYPING FOR HOMOTRANSPLANTATION. IX. EVALUATION OF LEUKOCYTE ANTIGEN MATCHING WITH THE CLINICAL COURSE AND REJECTION TYPES (1967) (28)
EFFECT OF BLOOD-GROUP ON RELATION BETWEEN HLA MATCH AND OUTCOME OF CADAVER KIDNEY TRANSPLANTS (1977) (28)
Thirty-year trends in clinical kidney transplantation. (1993) (28)
Autoimmune cytotoxic granulocyte antibodies in normal persons and various diseases. (1978) (28)
Cancer immunotherapy with HLA‐compatible thoracic duct lymphocyte transplantation. A preliminary report (1972) (28)
Antibody Response to Homografts. I. Technic of Lymphoagglutination and Detection of Lymphoagglutinins upon Spleen Injection.∗ (1959) (27)
Stimulation of lymphocyte transformation by streptococcal type M1 protein: relationship to HL-A antigens. (1972) (27)
THE LONG‐TERM OUTCOME OF OKT3 COMPARED WITH CYCLOSPORINE PROPHYLAXIS AFTER LIVER TRANSPLANTATION (1991) (27)
Detection of tumor-associated antigens in the sera of lung cancer patients by three monoclonal antibodies. (1985) (27)
HLA‐DR MATCHING IN MULTICENTER, SINGLE‐TYPING LABORATORY DATA (1982) (27)
Hl‐a in cancer family “n” (1975) (27)
A MICROGRANULOCYTE CYTOTOXICITY TEST1 (1973) (26)
Kidney preservation: perfusion versus cold storage-1975. (1976) (26)
The 90% incidence of HLA antigen (Te24) in dermatitis herpetiformis. (2008) (26)
Immunologic reconstitution in severe combined immunodeficiency wihout bone-marrow chromosomal chimerism. (1972) (26)
Lymphocytotoxins and pernicious anemia. (1972) (26)
RECIPIENT SELECTION FOR RENAL RETRANSPLANTATION (1976) (26)
Monoclonal antibody against A1 Lewis d antigen produced by the hybridoma immunized with a pulmonary carcinoma. (1982) (26)
Increased vulnerability of the donor organ in related kidney transplants for certain diseases. (1984) (26)
Histocompatibility testing, 1980 : report of the eighth International Histocompatibility Workshop held in Los Angeles, California, USA, 4-10 February 1980 (1980) (26)
History of Hla Ten Recollections (1990) (26)
Human Leukocyte Antigen Antibodies for Monitoring Transplant Patients (2005) (26)
The transfusion effect in cadaver kidney transplants--yes or no. (1990) (26)
Effect of transfusions. (1991) (25)
EFFECT OF SPLENECTOMY ON HUMAN RENAL TRANSPLANTS (1973) (25)
STRONG ASSOCIATION BETWEEN B-LYMPHOCYTE GROUP-2 SPECIFICITY AND ASTHMA (1976) (25)
Effect of HLA mismatch in African-Americans. (1998) (25)
Antigenic specificities detected on papainized human granulocytes by microgranulocytotoxicity. (1977) (24)
Onset and progression of de novo donor‐specific anti‐human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction (2015) (24)
IMPORTANCE OF PREOPERATIVE (NOT PEROPERATIVE) TRANSFUSIONS FOR CADAVER KIDNEY TRANSPLANTS (1981) (24)
Impact analysis: a method for evaluating the impact of factors in clinical renal transplantation. (1998) (24)
HLA-B14 antigen and postencephalitic Parkinson's disease. Their association in an American-Jewish ethnic group. (1980) (24)
HLA-DR and disease associations. (1981) (24)
HL-A types in atopic dermatitis. (1973) (24)
Predicting Operational Tolerance in Pediatric Living-Donor Liver Transplantation by Absence of HLA Antibodies (2013) (24)
HLA matching: a comparison of conventional and molecular approaches. (1992) (24)
Significance of a positive crossmatch on outcome in human liver transplantation. (1992) (23)
Living-Unrelated Donors Yield Higher Graft Survival Rates than Parental Donors (2005) (23)
Crossmatching with B and T cells and flow cytometry. (1986) (23)
Cytotoxins in disease. V. Various diseases. (1971) (23)
Influence of lymphocyte-dependent antibodies on human kidney transplants. (1974) (23)
Frequency of HLA-Dw3 in juvenile rheumatoid arthritis. (2008) (23)
SEROTYPING FOR HOMOTRANSPLANTATION: XXXI. A 45‐Minute Microcytotoxicity Test1 (1969) (23)
Long-Term Pancreas Allograft Survival in Simultaneous Pancreas-Kidney Transplantation by Era (2010) (23)
Paired kidney donation by shipment of living donor kidneys (2007) (22)
Prolonged Survival of Second Human Kidney Transplants (1972) (22)
HUMORAL SENSITIZATION IN PAROUS WOMEN: CYTOTOXIC ANTIBODIES TO NON HL‐A ANTIGENS (1976) (22)
Dynamics and epitope specificity of anti-human leukocyte antibodies following renal allograft nephrectomy. (2016) (22)
T-CeII Reconstitution by Thymus Transplantation and Transfer Factor in Severe Combined lmmunodeficiency (1975) (22)
Detection of HLA and MICA antibodies before kidney graft failure. (2006) (22)
The state of therapy for removal of alloantibody producing plasma cells in transplantation. (2012) (22)
Origins of the first HLA specificities. (2000) (22)
Senior citizens pool for aged kidneys. (1997) (22)
Matching kidneys for size in renal transplantation (1990) (21)
Profiles of black and Latin-American patients having pernicious anemia. HLA antigens, lymphocytotoxic antibody, anti-parietal cell antibody serum gastrin levels, and ABO blood groups. (1981) (21)
Outcome of preemptive renal transplantation versus waiting time on dialysis. (2002) (21)
Use of four monoclonal antibodies to detect tumor markers (1986) (21)
Trypsinization of lymphocytes for HL-A typing. (1972) (21)
THE LEWIS SYSTEM AND KIDNEY TRANSPLANTATION (1980) (21)
A brief history of HLA (2007) (21)
Specificity of lymphocytotoxic anti-human antibodies in normal rabbit sera. (2008) (21)
SEROLOGICAL CHARACTERIZATION OF NATURAL ANTIHUMAN LYMPHOCYTOTOXIC ANTIBODIES IN MAMMALIAN SERA (1973) (21)
KIDNEY PRESERVATION FOR TRANSPORTATION: II. A Simple Technique for 12‐hr Storage and Air Transport1 (1969) (21)
Detection of HL-A and other cell-surface antigens on cultured cells by a cytotoxic plating inhibition test. (1972) (21)
Landsteiner Award. HLA epitope matching (1992) (21)
Letter: Distribution of HLA haplotypes in polymyalgia rheumatica. (1976) (21)
Kidney paired donation--the next step. (2011) (21)
LYMPHOCYTE-DEPENDENT ANTIBODY CROSS-MATCHING FOR TRANSPLANT PATIENTS (1975) (21)
A comparison of kidney transplant survival in white and black recipients. (1989) (21)
Donor age and recipient age. (1988) (21)
Familial Hodgkin's disease and associated cancer. A Clinical‐Pathologic Study (1976) (21)
Antibody response to homografts. VII. The role of complement in cytotoxicity of serum from homografted rabbits. (1961) (21)
Quantitation of the microassay for cell-mediated immunity through electronic image analysis. (1973) (20)
CYTOTOXIC MONOCLONAL ANTIBODY TO A HUMAN LEIOMYOSARCOMA (1981) (20)
Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients. (2012) (20)
Deduction of 2140 HL-A haplotypes and segregation analysis in 535 families. (1973) (20)
Early rejection episodes. (1989) (20)
A monoclonal antibody cross-reactive with human platelets, megakaryocytes, and common acute lymphocytic leukemia cells (1983) (20)
The transfusion effect. (1986) (20)
UCLA liver transplantation: analysis of immunological factors affecting outcome. (2008) (20)
EXTRANEOUS LYMPHOCYTIC HL‐A ANTIGENS IN SEVERE COMBINED IMMUNODEFICIENCY DISEASE (1972) (20)
Effect of race on kidney transplants. (1990) (20)
DR antigens in bullous pemphigoid. (1984) (20)
Platelet crossmatching for kidney transplants by flow cytometry. (1989) (20)
No Occurrence of De Novo HLA Antibodies in Patients With Early Corticosteroid Withdrawal in a 5-year Prospective Randomized Study (2009) (20)
The UNOS Scientific Renal Transplant Registry--1991. (1991) (20)
DESTRUCTION OF EPIDERMAL CELLS IN VITRO BY AUTOLOGOUS SERUM FROM NORMAL ANIMALS (1962) (20)
Studies on the role of cellular immunity and genetics in the etiology of rapidly progressing breast cancer in tunisia (1981) (19)
Cytotoxic antibodies against surface immunoglobulin. (1980) (19)
Unrelated donors for bone-marrow transplantation and transfusion support: pool sizes required. (1974) (19)
Analysis of yearly kidney transplant survival rates. (1976) (19)
The HLA Complex (1985) (19)
Nomenclature for factors of the HLA system--1977. (1978) (19)
A microgranulocyte cytotoxicity test. (1973) (19)
Clinical kidney transplants, 1988. (1989) (19)
Antibody Response to Homografts VI. In vitro Cytotoxins Produced by Skin Homografts in Rabbits.∗ (1961) (19)
Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development. (2006) (19)
RENAL TRANSPLANTATION AT THE UNIVERSITY OF COLORADO (1967) (19)
Inhibition of anti-HL-A alloantisera by glycoproteins, polysaccharides, and lipopolysaccharides from diverse sources. (1973) (19)
HLA matching effect: better survival rates and graft quality. (1994) (19)
A cytotoxic monoclonal antibody to colon adenocarcinoma. (1984) (19)
Sjögren's syndrome association with HLA-Dw3. (1977) (19)
Significance of the HLA molecular structure to transplantation. (1988) (19)
HLA-D and DRw determinants in an American indigenous isolate. (1979) (19)
Measles antibody titers in multiple sclerosis patients and HLA‐matched and unmatched siblings (1981) (19)
Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers. (1982) (19)
New variables reported to the UNOS registry and their impact on cadaveric renal transplant outcomes - a preliminary study. (1995) (19)
Benefits of HLA-CREG matching for sensitized recipients as illustrated in kidney regrafts. (1997) (19)
MONOCLONAL ANTIBODY SPECIFIC FOR HUMAN T ACUTE LYMPHOBLASTIC LEUKAEMIA (1982) (19)
HL-A antigen in psoriasis. (1973) (19)
HLA-DR3 associated with improved kidney transplant survival. (1982) (18)
Recipient pool sizes for prioritized HLA matching. (1989) (18)
Empirical validation of the Essen-Möller probability of paternity. (1986) (18)
Kidney preservation for transportation. IV. Eight-thousand-mile international air transport. (1970) (18)
A monoclonal antibody, CSTO-1, against a stomach adenocarcinoma-associated antigen. (1984) (18)
A Single Human Leukocyte Antigen-Antibody Test After Heart or Lung Transplantation Is Predictive of Survival (2008) (18)
High survival rate of kidney transplants in IgA nephropathy patients (1992) (18)
Gastric cancer progression may involve a shift in HLA‐E profile from an intact heterodimer to β2‐microglobulin‐free monomer (2014) (18)
HL-A W29 and subacute sclerosing panencephalitis (1975) (18)
HLA-A2 and Type 2 (insulin independent) diabetes mellitus in Pima Indians: An association of allele frequency with age (1981) (18)
Advances in kidney transplantation: 1985-1995. (1995) (18)
Blood transfusions and HLA matching--an either/or situation in cadaveric renal transplantation. (1988) (18)
Twins with two different fathers identified by HLA. (1979) (17)
14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis. (2007) (17)
RENAL DAMAGE PRODUCED IN VIVO BY HOMOLOGOUS MOUSE ANTISERA * (1962) (17)
HLA-DR antigens in tuberculoid and lepromatous leprosy. (1980) (17)
Histocompatibility Workshop and Conference (2008) (17)
Autoimmune cytotoxic granulocyte antibodies in health and disease. (1977) (17)
Retrospective antibody analysis of thirty patients with kidney graft failure. (2006) (17)
Impact of immunosuppression on HLA-antibody formation. (2006) (17)
Living donor kidney transplants: superior success rates despite histoincompatibilities. (1997) (17)
Update of the University of California at San Francisco experience with donor-specific blood transfusions. (1982) (17)
STORAGE OF HUMAN LYMPHOCYTES AT ROOM TEMPERATURE (1974) (17)
ABH and Lewis antigens on lymphocytes: screening of pregnant women's sera with the B-cell cytotoxicity test. (1979) (17)
ANALYSIS OF INTERRACIAL VARIATION IN KIDNEY TRANSPLANT AND PATIENT SURVIVAL (1982) (17)
HLA-DR antibody epitopes. (2006) (17)
Immunologic classification of childhood acute lymphocytic leukemia (1981) (17)
Annual trends and triple therapy--1991-2000. (2001) (17)
Cytotoxicity of anti-Fab antibodies against B lymphocytes in rheumatoid arthritis. (1981) (17)
Prolonged hypertension (> 10 years) is a significant risk factor in older cadaver donor renal transplants. (1999) (17)
Improved HLA-DR typing of dialysis patients using monoclonal antibodies. (1982) (16)
Leucocyte Antigens in Man : A Comparison of Lymphocytotoxic and Agglutination Assays for their Detection (1966) (16)
Histocompatibility matching. V. A comparison of typing and mixed cultures in unrelated individuals. (2008) (16)
Reduction of accelerated failures by transfusion. (1982) (16)
Human IgM anti-IgM cytotoxin for B lymphocytes. (2008) (16)
Effect of water-soluble adjuvants on in vitro lymphocyte immunization. (1975) (16)
QUANTITATIVE DETERMINATION OF ANTIBODY AND COMPLEMENT DIRECTED AGAINST LYMPHOCYTES. (1964) (16)
Low serum OKT3 levels correlate with failure to prevent rejection in orthotopic liver transplant patients. (1990) (16)
Suppression of allo‐human leucocyte antigen (HLA) antibodies secreted by B memory cells in vitro: intravenous immunoglobulin (IVIg) versus a monoclonal anti‐HLA‐E IgG that mimics HLA‐I reactivities of IVIg (2014) (16)
Association of DR4 with pemphigus. (1987) (16)
A preliminary report on the role of some immunologic factors in persistence of chronic tinea pedis (1985) (16)
Clonal deletion using total lymphoid irradiation with no maintenance immunosuppression in renal allograft recipients. (2009) (16)
New HLA class I epitopes defined by murine monoclonal antibodies. (2010) (15)
Serological characterization of human monocytes for HLA, B-lymphocyte, granulocyte, and monocyte-associated antigens by cytotoxicity testing. (1978) (15)
Improving success rates of kidney transplantation. (1983) (15)
Serotyping for homotransplantation. XVI. Analysis of kidney transplants from unrelated donors. (1968) (15)
Serotyping for homotransplantation. XIX. Experience with an interhospital scheme of cadaver-kidney sharing and tissue typing. (1969) (15)
Refinement of permissible HLA mismatches. (1994) (15)
Factors important in 10-year kidney transplant survival. (1986) (15)
Heterogeneity of HL-A specificities shown by platelet complement-fixation. (2008) (15)
Anti-HLA-E monoclonal antibodies reacting with HLA-la and lb alleles like IVIg as potential IVIg-immunomimetics: an evolving therapeutic concept. (2013) (15)
HLA class I epitopes: A and B loci. (2006) (15)
COMPARISON OF MALE AND FEMALE KIDNEY TRANSPLANT SURVIVAL RATES (1972) (15)
SIX‐ANTIGEN‐MATCHED TRANSPLANTS: CAUSES OF FAILURE (1993) (15)
Summary of kidney transplant data, 1977-factors affecting graft outcome. (1978) (14)
HLA matching: maximizing the number of compatible transplants. (1993) (14)
A rapid metabolic screening test to evaluate potential cadaveric kidney donors (1967) (14)
Epitopes of HLA antibodies found in sera of normal healthy males and cord blood. (2008) (14)
Overview and epitope matching. (1989) (14)
HLA B27 and sacroiliitis in Pima Indians--association in males only. (1977) (14)
Should excessive height and weight differences between the kidney donor and recipient be avoided? (1997) (14)
Genetic linkage and spinocerebellar ataxia. (1978) (14)
Current trend of induction and maintenance treatment in positive panel-reactive antibody patients: a report on OPTN/UNOS kidney transplant registry data. (2011) (14)
Masking of human transplantation antigens by diverse substances. (1972) (14)
UNEXPECTED MANIFESTATIONS OF INDUCED TOLERANCE TO SKIN HOMOGRAFTS IN THE CHICKEN (1958) (14)
Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejection. (2016) (14)
Cardiac transplantation. Selection, immunosuppression, and survival. (1988) (14)
Low HL-A2 frequency and periodontitis. (1975) (14)
Changes in Successive Measures of De Novo Donor-Specific Anti–Human Leukocyte Antigen Antibodies Intensity and The Development of Allograft Dysfunction (2014) (14)
Antibody-dependent lymphocyte killer function in human immunodeficiency diseases. (1975) (14)
Improved graft survival following donor-specific blood transfusions. (1981) (13)
THE ASSOCIATION OF AN HLA‘ASTHMA‐ASSOCIATED’ HAPLOTYPE AND IMMEDIATE HYPERSENSITIVITY IN FAMILIAL ASTHMA (1981) (13)
A preclinical model to assess the antigenicity of an HLA‐A2 melanoma cell vaccine (1993) (13)
Flow cytometry crossmatching for kidney transplantation. (1988) (13)
Enhancement of kidney graft survival by blood transfusions. (1977) (13)
Bone marrow from cadaver donors for transplantation. (1985) (13)
Correlation of MLC response with graft survival in cadaver and related donor kidney transplants. (1978) (13)
Net histocompatibility ratios (NHR) for clinical transplantation. (1971) (13)
The Monospecificity of Novel Anti-HLA-E Monoclonal Antibodies Enables Reliable Immunodiagnosis, Immunomodulation of HLA-E, and Upregulation of CD8+ T Lymphocytes. (2015) (13)
Association of anti-Fab and anti-IgG antibodies with high kidney transplant survival. (1982) (13)
Correlation between number of pretransplant blood transfusions and kidney graft survival. (1979) (13)
ANTIBODY RESPONSE TO HOMOGRAFTS: V. CYTOTOXIC EFFECTS UPON LYMPHOCYTES AS MEASURED BY TIME‐LAPSE CINEMATOGRAPHY * (1960) (13)
Longitudinal testing of seventy-six renal allograft patients for HLA antibodies: Maastricht experience. (2006) (13)
Trends and Characteristics in Early Glomerular Filtration Rate Decline After Posttransplantation Alloantibody Appearance (2013) (13)
Cell surface antigens detected on mature and leukemic granulocytic populations by cytotoxicity testing. (1978) (13)
International cell exchange. (1978) (13)
Second kidney transplants and presensitization. (1972) (13)
Outcome of renal transplantation in different primary diseases. (1991) (13)
Histocompatibility and clinical kidney transplants. (1974) (13)
High kidney graft survival rates using non-heart-beating trauma donors. (1998) (13)
Cold-reactive antibodies to B lymphocytes and their absorption by platelets and red cells. (1977) (13)
Nomenclature for factors of theHLA system, 1991 (1992) (13)
Discrimination of T, B, and null lymphocytes by electronic sizing. (2008) (13)
STORAGE AND TRANSPORT OF 83 HUMAN KIDNEYS BY SIMPLE HYPOTHERMIA (1971) (13)
Utilization of cultured human lymphoid cells for detection of humoral sensitization in prospective recipients of kidney transplants. (1975) (13)
Human leukocyte antigens in cutaneous T cell lymphoma. (1985) (13)
Saliva as DNA source for HLA typing. (1998) (13)
Detailed examination of HLA antibody development on renal allograft failure and function. (2008) (12)
EXAMINATION OF THE CLONAL DELETION HYPOTHESIS FOLLOWING TRANSFUSIONS IN RAT CARDIAC TRANSPLANTS (1987) (12)
ASSOCIATION OF ANTI‐F(ab')2 ANTIBODIES WITH HIGHER KIDNEY TRANSPLANT SURVIVAL RATES (1982) (12)
Augmentation of anti-HLA-E antibodies with concomitant HLA-Ia reactivity in IFNγ-treated autologous melanoma cell vaccine recipients* (2012) (12)
Effect of donor-specific transfusions on renal transplantation in children. (1985) (12)
HLA-linked and unlinked determinants of multiple sclerosis (2004) (12)
Factors influencing kidney graft survival in the cyclosporine era: a multivariate analysis. (1987) (12)
Histocompatibility testing in transplantation. (1991) (12)
HLA-DR antigens in Japanese with Hashimoto's thyroiditis and Graves' disease. (1982) (12)
Nomenclature for factors of the HLA system--1977. (1977) (12)
Histocompatibility leukocyte antigen patterns in nasopharyngeal carcinoma cases from California. (1977) (12)
Multiple sclerosis in the Orkney and Shetland Islands. V: The effect on viral titres of histocompatibility determinants. (1980) (12)
Cold Ischemia Time—Time to Rethink the Risk for Kidneys? (2011) (12)
SEROTYPING FOR HOMOTRANSPLANTATION. VIII. GROUPING OF ANTISERA FROM VARIOUS LABORATORIES INTO FIVE GROUPS. * (1966) (12)
Effect of HLA typing and transfusions on cyclosporine-treated renal allograft recipients. (1984) (12)
Linkage studies on glyoxalase I (GLO), pepsinogen (PG), spinocerebellar ataxia (SCA1), and HLA. (1980) (12)
HLA-DR4 in Negro and Mexican rheumatoid arthritis patients. (1981) (12)
The UNOS Scientific Renal Transplant Registry: multistep regression models on kidney graft survival. (1990) (12)
Improved graft survival with donor-specific transfusion pretreatment. (1981) (12)
Group-specific human granulocyte antigens on a chronic myelogenous leukemia cell line with a Philadelphia chromosome marker. (1977) (12)
NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1990 (1991) (12)
The current trend of induction and maintenance treatment in patient of different PRA levels: a report on OPTN/UNOS Kidney Transplant Registry data. (2010) (12)
HLA association studies in black sarcoidosis patients. (1978) (12)
Serology and genetics of Te58(W18) and other specificities included in the 4c complex. (2008) (12)
Brief Communication: Immunization of Lymphocytes From Cancer Patients (1974) (12)
A study of HLA antigens and haplotypes in a population of Caucasians with acute non-lymphocytic leukemia. (1979) (12)
HLA-A* 1104: a new allele found in a Laotian family. (1996) (12)
Lack of association of HLA-A and B locus antigens with relapsing polychondritis. (2008) (11)
Histocompatibility testing 1970 : report of an international workshop held at UCLA and Palm Springs, California, U.S.A. 20-26, January 1970 and the Fourth International Histocompatibility Conference at Los Angeles, California, U.S.A. 27-29, January 1970 (1970) (11)
Influence of interval between first graft removal and retransplantation on outcome of second cadaver kidney grafts. (1976) (11)
Serotyping for homotransplantation. XXIV. Heart transplantation (1969) (11)
Antibody responses following rubella immunization analyzed by HLA and ABO types (1977) (11)
Retrospective tests of B-cold lymphocytotoxins and transplant survival at a single center. (1979) (11)
HLA-DR and HLA-A, B, C typing of human fetal tissue. (2008) (11)
Studies of HLA-A, -B, -C, and -D antigens on monocytes. (1978) (11)
A report from the UNOS Scientific Renal Transplant Registry. (1991) (11)
Influence of HLA and CREG matching in African-American primary cadaver kidney recipients: UNOS 1991-1995. (1997) (11)
Effect of blood transfusions on survival after cancer surgery. (1985) (11)
Humoral theory of transplantation: some hot topics. (2013) (11)
Unrelated living donor kidney transplants. (1997) (11)
Immunohistochemical examination of lung cancers using monoclonal antibodies reacting with sialosylated Lewisx and sialosylated Lewisa (1987) (11)
Sensitization to kidney transplants. (1990) (11)
The UNOS Scientific Renal Transplant Registry--1990. (1990) (11)
Sensitization 2001. (2001) (11)
Unexpected frequencies of HLA antibody specificities present in sera of multitransfused patients. (2006) (11)
Immunogenicity of soluble HL-A alloantigens. (1972) (11)
Sensitization after transplantation. (1987) (11)
Connective tissue diseases. (1983) (11)
Superior renal allograft survival among Asian recipients. (1992) (11)
Direct detection of PCR products for HLA class II typing. (1993) (11)
Histocompatibility antigens and humoral immunity to Epstein-Barr virus. (2008) (11)
Improved DR typing of cadaver donor by lymphocyte incubation. (1981) (11)
Nature and Clonality of the Fluoresceinated Secondary Antibody in Luminex Multiplex Bead Assays Are Critical Factors for Reliable Monitoring of Serum HLA Antibody Levels in Patients for Donor Organ Selection, Desensitization Therapy, and Assessment of the Risk for Graft Loss (2017) (11)
The center effect: is bigger better? (1999) (11)
HLA polymorphisms, ethnicity, and graft survival: united network for organ sharing. UNOS Scientific Renal Transplant Registry. (1993) (10)
The long-term effect of primary disease on cadaver-donor renal transplant recipients. (1993) (10)
Detection of antibodies against major histocompatibility complex class I-related chain A in long-term renal graft recipients. (2012) (10)
A monoclonal antibody recognizing a determinant common to HLA-A3 and A11. (1982) (10)
SEROTYPING FOR HOMOTRANSPLANTATION: XXIX. Two NEW HL-A ANTIGENS (1969) (10)
Bone marrow from cadaver donors for transplantation (1985) (10)
Identification of surface IgM as the target antigen of cold lymphocytotoxins. (2008) (10)
Donor and recipient age effect. (1986) (10)
12-P: A Novel HLA Class I Single Antigen Bead Preparation Eliminates False Positive Reactions Attributed to Natural Antibodies – in the Sera of Normal Males and Pre-Transplant Patients (2010) (10)
HLA class I epitopes accounted for by single residues. (1991) (10)
HLA-Bw44 and HLA-DRw4 in male Sjögren's syndrome patients with associated rheumatoid arthritis. (1980) (10)
HLA peptide matching. (1991) (10)
Absence of HLA-DRW2 in Japanese pemphigus vulgaris. (1981) (10)
The review by Kwun and Knechtle-"can it B?"-asks whether B cells are responsible for chronic rejection of transplants. (2009) (10)
HLA typing in amyotrophic lateral sclerosis. (1986) (10)
Combined effects of HLA matching and age in renal transplantation. (1980) (10)
Screening of high cytotoxic tumor killer cells using a sensitive adherent target detachment assay. (2004) (10)
Association studies between type 1 (insulin-dependent) diabetes and 27 genetic markers: Lack of association between type 1 diabetes and kidd blood group (1983) (10)
Antigen Report: HLA-DQw1 (1984) (9)
Reduction of the center effect by HLA matching. (1993) (9)
Significance of HLA and non-HLA antigens in bone marrow transplantation. (1978) (9)
Nomenclature for factors of the HLA system, 2004. (2005) (9)
OKT3 prophylaxis in liver transplantation (1991) (9)
Molecular HLA matching. (1991) (9)
National donor registry and computer transfusion programs for platelet transfusions. (1977) (9)
Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients. (1987) (9)
A new simplified method of gene typing. (1994) (9)
HLA compatibility can be predicted by matching only three residues with outward oriented sidechains. (1996) (9)
Sensitization effect. (1986) (9)
APPEARANCE OF THE TUMOR MARKER CA 19–9 IN LIVER TRANSPLANT PATIENTS DURING REJECTION EPISODES (1992) (9)
An antigen expressed by cells of the myelo‐monocytic lineage (1981) (9)
Epstein-Barr virus antibodies and histocompatibility type in multiple sclerosis. (1977) (9)
Graft survival rates and HLA antigen frequencies in renal cadaver transplant recipients with hepatitis B antigenemia. (1978) (9)
First and second B-lymphocyte antigen expression in malignant melanoma. (1980) (9)
PRESENSITIZATION TO TRANSPLANTS DETECTED BY CELLULAR IMMUNITY TESTS (1971) (9)
Impact of the presence and duration of donor-specific antibodies on renal function. (2014) (9)
Allogeneic cell-mediated testing for human tumor antigens. (1972) (9)
Pre‐existing anti‐HLA antibodies negatively impact survival of pediatric aplastic anemia patients undergoing HSCT (2014) (9)
Renal transplantation update. (1984) (9)
Detection of differentiation antigens by use of monoclonal antibodies. (1981) (9)
Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant alpha-helical motifs produce complex serologic recognition patterns for the HLA-B"DT" and HLA-B"NM5" antigens. (1995) (8)
LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY‐THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 13/4–21/2 YEARS AFTER TRANSPLANTATION * (1966) (8)
Prolongation of hepatic allograft survival in rat recipients treated with anti-lymphotoxin antibody. (1991) (8)
Binding of IgG to B cell via HLA molecules. (1991) (8)
Decreased transplant survival rate of shared and nonshared machine-preserved cadaver kidneys. (1977) (8)
B cell alloantigens in juvenile rheumatoid arthritis. (1978) (8)
Fifteen years of HL-A: what is the importance of HL-A compatibility for clinical outcome of renal transplantations? (1978) (8)
Mimetic Human Leukocyte Antigen Epitopes: Shown by Monoclonal Antibodies and Extra Antibodies Produced on Transplantation (2008) (8)
HL-A Histocompatibility determinants. (1971) (8)
Loss of HLA-C locus specificities from stored lymphocytes1 and de novo synthesis following incubation at 37°C (1981) (8)
HLA-DR specificities among Japanese with rheumatoid arthritis. (1981) (8)
The specificity of tolerance to homografts in the chicken. (1958) (8)
Genetic polymorphisms in southwest Alaskan Eskimos. (1991) (8)
T-cell reconstitution by thymus transplantation and transfer factor in severe combined immunodeficiency. (1975) (8)
Serotyping for homotransplantation. XXV. Evidence for three HL-A subloci. (1969) (8)
Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A (2005) (8)
HLA antigens in stomach cancer (1980) (8)
Tolerogenic Mechanisms in Liver Transplantation (2015) (8)
HLA frequencies in cancer: a third study. (1978) (8)
Racial effect on kidney transplants. (1987) (8)
A new acute leukemia-associated blast cell antigen detected by a monoclonal antibody (1982) (8)
Suppression of mixed leukocyte response by plasma from hemodialysis patients. (2008) (8)
Chronic survival after human renal homotransplantation: Lymphocyte- antigen matching, pathology and influence of thymectomy (1966) (8)
A Congressional Gold Medal for Transplant Donors and Families (2005) (8)
Proceedings: HL-A antigen W27 in juvenile chronic polyarthritis. (1974) (8)
Inhibition of transplant vasculopathy is associated with attenuated host allo-antibody response. (1999) (8)
Determinants of effectiveness of thoracic duct drainage for primary cadaver kidney transplantation. (1981) (8)
Blocking of HLA and B lymphocyte alloantigens with F (ab')2 fragments of rabbit antibodies. (1976) (7)
Factors important in ten-year kidney graft survival. (1987) (7)
The benefit and underutilization of sharing kidneys for better histocompatibility. (1989) (7)
Antibody response and allograft outcome with deliberate donor-specific blood transfusions. (1982) (7)
Incidence and role of antibody in graft injury: How can it best be monitored? (2004) (7)
Characterization and Isolation of HL-A Antigens from Continuous Cultured Human Lymphocyte Cell Lines: A Report of Current Progress (1972) (7)
Flow cytometry crossmatching for kidney transplantation. (1993) (7)
SEROTYPING FOR HOMOTRANSPLANTATION. XI. GROUP CLASSIFICATION BASED ON POSTERIOR PROBABILITIES (1967) (7)
Serologic specificity and crossreactivity of soluble HL-A alloantigens. (1972) (7)
Prediction of negative crossmatch: an aid for cost-effective kidney sharing. (1982) (7)
HL-A antigens associated with lupus erythematosus. (1972) (7)
BCG treatment of Crohn's disease. (1979) (7)
Impact of new variables reported to the UNOS registry. (1997) (7)
DR-bearing T lymphocytes in thoracic duct lymph. (1981) (7)
Role of antibodies to B lymphocytes in renal transplantation. (1977) (7)
Study of factors influencing induced tolerance to skin homografts in the chicken. (1957) (7)
Human autoimmunity, with pernicious anemia as a model. (1974) (7)
IgM anti-IgM cold lymphocytotoxins to B cells. (1979) (7)
Current investigation in the homograft problem. (1957) (7)
Detection of Combined ABH and Lewis Glycosphingolipids in Sera of H‐Deficient Donors (1985) (7)
Outcome of renal transplantation in blacks. (1987) (7)
Unexpected frequencies of HLA antibody specificities in the sera of pre-transplant kidney patients. (2006) (7)
A report of 504 six antigen-matched transplants. (1991) (7)
UCLA and UNOS Registries. Overview. (1991) (7)
Immunogenic HLA class I epitopes identified by humoral response to pregnancies. (2008) (7)
The role of B-lymphocyte antigens in MLC stimulation. (1977) (7)
Serologic and biochemical analysis of HLA B15 and B5 complexes. (1987) (7)
Regarding the ankylosing spondylitis/Klebsiella/HLA-B27 problem. (1987) (7)
HLA epitopes and graft survival. (1991) (7)
The antigenic stimulus in human transplantation. (1973) (7)
Donor-specific transfusion. (1986) (7)
Transport of lymphocytes for typing. (1969) (7)
The use of computer programs for tissue typing and immunogenetic research. (2008) (7)
National transplant communications network. (1971) (6)
Fifteen-year overview of the International Cell Exchange. (1989) (6)
HLA-DR1 recipients have the highest kidney transplant survival. (1987) (6)
HL-A typing in Asian Indians. (2008) (6)
ABO mismatching errors in heart transplants (2003) (6)
ANTIBODY‐DEPENDENT CELL‐MEDIATED CYTOTOXICITY TESTS FOR IMMUNOSUPPRESSION MONITORING OF TRANSPLANT PATIENTS (1979) (6)
Cytomegalovirus antibody status and kidney transplantation. (1994) (6)
Interspecies reactivity and intraspecies specificity of antilymphoid globulin. (1967) (6)
Evaluation of the transplant recipient and donor: molecular approach to tissue typing, flow cytometry and alternative approaches to distributing organs (1997) (6)
Outcome of kidney transplantation in different diseases. (1990) (6)
Human lymphoblastoid cell lines secreting antibodies with restricted HLA specificity (2004) (6)
International Cell Exchange, 1994. (1994) (6)
Prospective estimates of probability of success of kidney transplants: a basis for recipient selection. (1979) (6)
Rheumatology and Joint Diseases (1985) (6)
Novel alleles HLA-B*7802 and B*51022: evidence for convergency in the HLA-B5 family. (1996) (6)
PROLONGATION OF SECOND HEART TRANSPLANTS IN RATS (1992) (6)
Early graft function. (1986) (6)
Allocation of cadaver kidneys (1996) (6)
Analysis of Class II RFLP Patterns and T-Cell Clone Reactions (1989) (6)
Low kidney graft survival in Lewis negative patients after regrafting and newer matching schemes for Lewis. (1987) (6)
Immunobiology of HLA Class-Ib Molecules in Transplantation (2015) (6)
Effect of mismatching serologically defined residues on kidney transplant survival. (1992) (6)
Current world opinion regarding the use of living donors. (1994) (6)
The effect of size and donor age on survival of skin homografts in newly hatched chicks. (1957) (6)
Deliberate buffy-coat transfusions and the risk of antibody formation. (1982) (6)
The second histocompatibility locus in humans. (1988) (6)
Effect of anti-Fab antibodies on renal allografts. (1991) (6)
HUMAN COMPLEMENT IN TREATMENT OF BONE MARROW CELLS WITH MONOCLONAL ANTIBODY (1983) (6)
Report on 604 six-antigen-matched transplants. (1990) (6)
HLA matching for improved cadaver kidney allocation. (1994) (6)
Clinical transplants 1988. Overview. (1988) (6)
Graft survival with high levels of cytotoxic antibodies. (1981) (6)
Cross-reactivity between human and murine lymphocyte antigens: III. Reactivity of H-2 allo- and xenoantisera with human lymphoid cells (1974) (6)
Comparison of kidney graft survival in Asian and Caucasian patients transplanted in the United States. (1996) (5)
HLA-B*4012: a new allele with unique serological features. (2000) (5)
Ten-year progress report of the International Cell Exchange. (1984) (5)
Association of high sensitization to the structure of HLA class I alleles. (1991) (5)
Dilutions and specificity analysis of pretransplant sera. (1979) (5)
Heart transplantation in the United States 2004. (2004) (5)
Beneficial Effect of Transfusion on Kidney Transplants (1989) (5)
National utilization of cadaver kidneys for transplantation. (1974) (5)
Enhancing antibody in human renal transplantation. (1979) (5)
1990 cell typings in the International Cell Exchange. (1990) (5)
Relationshipp of HLA-Dw3 and HLA-B8 to Sjögren's syndrome. (1978) (5)
Kidney transplantation trends from UCLA registry Data, 1975-1982. (1983) (5)
HLA serologic epitopes. (1989) (5)
Removal of physiologic corticosteroid doses results in HLA antibody appearance and allograft dysfunction in patients transplanted under a clonal deletion protocol. (2009) (5)
Pediatric kidney transplantation utilizing living unrelated donors: anecdote or solution to the kidney shortage? (1998) (5)
Non-HLA antibodies after rejection of HLA identical kidney transplants. (2006) (5)
International sera exchange analyses in relation to DNA sequences: summary report from 1990 to 1994. (1994) (5)
Microtest for red cell typing (1985) (5)
Studies of sera from IgA nephropathy patients to explain high kidney graft survival (1991) (5)
OFFSPRING TO MOTHER KIDNEY TRANSPLANTS An Example of Donor‐Specific Immunized Transplants (1982) (5)
Kidney transplantation from living‐unrelated donors (1996) (5)
Role of proteasome inhibition in sensitized transplant candidates. (2011) (5)
An alternative to cadaver kidney transplants for patients with insulin-dependent diabetes mellitus. (1981) (5)
HLA class II epitope detection by serology. (1990) (5)
ANTIBODY RESPONSE TO HOMOGRAFTS (1961) (5)
Molecular matching for clinical kidney transplantation. (1993) (5)
Risk Stratification of Human Leukocyte Antigen Class II Donor Specific Antibody Positive Patients by Immunoglobulin G Subclasses. (2015) (5)
Induction of tolerance to homografts by nonspecific pooled blood. (1958) (5)
Frozen blood transfusions and renal allograft survival. (1976) (4)
Improved allograft survival in nonidentical living related donor transplants using donor-specific blood transfusions. (1985) (4)
The effect of cyclosporine A in cadaver donor retransplants: a surprising effect of the sex of the donor. (1987) (4)
Serum creatinine levels in 10-year survivors of cadaveric kidney transplants. (2003) (4)
Proposed HLA matching scheme for improved cadaveric kidney allocation. (1995) (4)
Mortality of Chick Embryos upon Injection of Homologous Adult Cells.∗ (1959) (4)
A city-wide scheme for cadaver kidney procurement, sharing, and tissue typing. (1968) (4)
Prospective study of kidney transplantation across positive T warm crossmatches. (1989) (4)
A study of HLA and DRw antigens in severe recurrent herpes progenitalis (HSV-2) infection. (1982) (4)
HLA epitopes for kidney allocation. (1998) (4)
Experience with forty-seven renal homotransplantations from cadaveric donors with emphasis on the donor with marginally acceptable kidneys. (1969) (4)
Posttransplant serum analysis in human kidney allografts. (1981) (4)
Simultaneous antibody-mediated rejection of multiple allografts in modified multivisceral transplantation. (2006) (4)
Low anti-A and anti-B titers in some type O patients may permit renal transplantation across the ABO barrier. (1987) (4)
Antibody response to homografts. IV. Time of appearance of lymphoagglutinins in partially tolerant animals. (1960) (4)
Beneficial effect of sharing six-antigen-matched cadaver kidneys in the United States. (1992) (4)
Histocompatibility-transplant correlation, reproducibility, and new matching methods. (1971) (4)
SEROTYPING FOR HOMOTRANSPLANTATION1: XXXII. HL‐A Haplotypes in Japanese Families (1969) (4)
Serum creatinine as a predictor of transplant survival and death. (2004) (4)
Miniaturized whole blood ADCC assay of depressed effector activity in cancer patients. (2008) (4)
Antibodies to human immunoglobulin detected by hemolysis of human immunoglobulin-coated red blood cells. (2008) (4)
Preliminary evidence of dual-marked lymphocytes in thoracic duct lymph fluid. (1980) (4)
MOST PATIENTS WHO REJECT A KIDNEY TRANSPLANT HAVE ANTI‐HLA‐ANTIBODIES (2002) (4)
Antigen Society #35 Report DQw4 [DQ “WA”]) (1989) (4)
A simple, rapid micro-latex fixation test. (1979) (3)
The History of HLA and Transplantation (2013) (3)
Influence of rejection of the first transplant on the outcome of subsequent transplants (1997) (3)
Antigen Society #33 Report (Public Epitopes) (1989) (3)
LOW‐DOSE CYCLOSPORINE MAINTENANCE THERAPY AFTER IMMUNOSUPPRESSIVE INDUCTION IN A RAT CARDIAC TRANSPLANT MODEL (1988) (3)
Lymphocyte response to IgG in patients with ankylosing spondylitis and their families. (1976) (3)
A "new" road to tolerance: clonal deletion and drugs added when needed (DAWN). (2010) (3)
Antigen Report: HLA-Bw54, HLA-Bw55, and HLA-Bw56 (1984) (3)
HLA in breast cancer-prone families and the cancer family syndrome. (1977) (3)
Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect. (1987) (3)
Nomenclature for factors of the HLA system, 2000. (2001) (3)
High graft survival rates for black recipients of HLA-matched renal transplants (1994) (3)
Nomenclature for Factors of the HLA System 1977 (1977) (3)
HLA MATCHING AND CYCLOSPORIN IMMUNOSUPPRESSION: A STRONG CORRELATION (1986) (3)
Ninety-five percent probability of paternity with HLA, ABO and haptoglobins. (1978) (3)
IMPROVEMENT OF KIDNEY TRANSPLANT REGRAFT RESULTS BY USING TRAUMA DEATH DONORS (1987) (3)
B-lymphocyte antigens in three racial groups. (1977) (3)
International Cell Exchange: 1992. (1992) (3)
Nationwide organ sharing using HLA typing. (1991) (3)
Tissue Typing in Human Kidney Transplantation (1973) (3)
Permissible class I mismatches identified from 7-year kidney transplant successes with 4 AB mismatches (1994) (3)
Naturally Occurring Anti-HLA-E Autoantibodies: Evidences of HLA-Ia Reactivity of Anti-HLA-E Antibodies (2014) (3)
Matching cadaver transplants achieve graft survivals comparable to living related transplants. (1991) (3)
HLA epitopes detected by serology. (1990) (3)
Arguments against HLA-A, -B, -DR mismatching in kidney transplant recipients. (1989) (3)
Depressed effector cell function in antibody-dependent cell-mediated cytotoxicity in kidney allograft recipients. (1977) (3)
Donor-specific preformed B-lymphocyte antibodies and mixed lymphocyte culture (MLC) blocking in cadaver renal allograft recipients. (1978) (3)
The role of HLA typing in clinical kidney transplants: 30 years later. Indisputable fact regarding clinical organ transplantation. (1993) (3)
High graft survival with spousal and 2-HLA-haplotype mismatched sibling-donor transplants. (1994) (3)
Factors influencing effect of HLA matching on cadaver kidney transplants. (1977) (3)
HLA matching for local pools using fewer HLA factors. (1995) (3)
Allograft immunogenicity by absorption test. (2008) (3)
Microassays in transplantation immunology. (1971) (3)
Improved Long-Term Survival in Kidney Transplant Recipients with Donor-Specific HLA Antibodies After Mycophenolic Acid Escalation. (2014) (3)
B-lymphocyte haplotypes in asthma families. (1977) (3)
Renal retransplantation. (1994) (2)
Impact of allocating cadaveric kidneys solely to "centers of excellence" versus by HLA matching. (1995) (2)
Inhibition of mixed lymphocyte culture reaction by cold cytotoxins. (1983) (2)
Empirical paternity exclusion rates. (1987) (2)
Donor-specific HLA antibody response in clonal deletion. (2008) (2)
1.1-01 Detection of new HLA-ABC variants through the international cell exchange, 1988–1989 (1989) (2)
International Cell Exchange, 1991. (1991) (2)
Evaluation of the UNOS point system for kidney recipient selection. (1989) (2)
TRANS‐PACIFIC KIDNEY SHIPMENT (1983) (2)
Crossmatching on platelets by flow cytometry. (1988) (2)
National kidney sharing and kidney preservation. (1977) (2)
Immunization of lymphocytes from cancer patients. (1974) (2)
LYMPHOCYTE TRANSFORMATION INDUCED BY HUMAN GRANULOCYTES (1975) (2)
Transplant Antigens: A Brief History of HLA (2014) (2)
Two independent HLA-B-locus specificities expressed on a single haplotype. (1979) (2)
A report on 341 six-antigen matched transplants. (1989) (2)
Nomenclature for Factors of the HLA System‐1977 1 (1979) (2)
LYMPHOCYTOXIC ANTIBODY RESPONSES TO TRANSFUSIONS IN POTENTIAL KIDNEY TRANSPLANT RECIPIENTS (1981) (2)
Specific inhibition of HL-A alloantisera by various carbohydrate-containing macromolecules. (1975) (2)
LA Class I Epitopes: Recognition of inding Sites by mAbs or Eluted lloantibody Confirmed With Single ecombinant Antigens (2007) (2)
Practical view of DR52 and DR53 locus (1988) (2)
Polymorphism at codons 114, 116, 145, and 163 muddle the typing of HLA-B*1304. (1997) (2)
PREFERENTIAL EFFECTIVENESS OF CYCLOSPORIN IN PATIENTS RECEIVING KIDNEY TRANSPLANTS AFTER GLOMERULONEPHRITIS (1985) (2)
Nomenclature for factors of the HLA System, 1998. (1999) (2)
Blood transfusions and renal transplantation. (1979) (2)
Responsiveness to HL-A as studied by monitoring blood transfusions and kidney transplants. (1973) (2)
Five subtypic specificities of the Bw22 complex in four racial groups. (1978) (2)
Nomenclature for factors of the HLA system, 1990. The WHO Nomenclature Committee for factors of the HLA system. (1991) (2)
Nomenclature for factors of the HLA system, 1995, update June 1995 (1995) (2)
Absorption studies of non-HLA cytotoxins. (1978) (2)
Class I peptides involved in the indirect pathway of allorecognition. (1998) (2)
Is there a differential strength of specific HLA mismatches in kidney transplants? (2008) (2)
Examination of the clonal deletion hypothesis following transfusions in rat cardiac transplants. (1987) (2)
Nomenclature for factors of the HLA system, 1996. (1997) (2)
The Transfusion Effect in Renal Allograft Recipients (1984) (2)
INHIBITION OF TRANSPLANT VASCULOPATHY BY PRAVASTATIN IS ASSOCIATED WITH ATTENUATION OF HOST ALLO-ANTIBODY RESPONSES (1998) (2)
Antigen Report: HLA-DR7 (1984) (2)
Significance of the differences in the prevalence of anti-HLA antibodies in matched pairs of mother's and cord blood. (2016) (2)
A proposal to increase donations of cadaveric organs. (1989) (2)
HLA peptide matching. (1991) (2)
The Los Angeles Transplant Society. (1986) (2)
EVIDENCE FOR INDEPENDENT MUTATION OF THE 21-HYDROXYLASE DEFICIENCY (210H DEF) GENE IN ALASKAN ESKIMOS WITH CONGENITAL ADRENAL HYPERPLASIA (CAH) (1984) (2)
B lymphocyte and histocompatibility antigens in extrinsic asthma. (1977) (2)
HLA-DP Region Complexity by CDC, RFLP, and Cellular Assays (1989) (2)
88-P: HLA class I epitopes of antibodies found in sera of normal healthy males and cord blood (2009) (2)
A review of the past 25 years of "Clinical Transplants". (2009) (2)
Blood Transfusions and HLA Matching—An Either/or Situation in Cadaveric Renal Transplantation (1988) (2)
Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells: Lymphocyte-dependent antibody studies with rabbit antisera☆ (1977) (1)
Time-lapse cinematography studies of the in vitro action of serum from homografted animals. (1960) (1)
24-P: Pre transplant anti MICA antibodies and long term follow up in deceased donor kidney transplants (2007) (1)
Successful transportation of kidneys between distant centers in North America. (1971) (1)
Specific removal of anti-red cell blood group activity from anti-HLA lymphocytotoxic sera and purification of anti-A and anti-B antibodies with lymphocytotoxic activity. (2008) (1)
Cadaver kidney transplant outcome following challenge with alloantigens. (1978) (1)
LONG TERM EFFECT OF INCREASED MYCOPHENOLIC ACID (MPA) ON DONOR SPECIFIC HLA ANTIBODY (DSA) STRENGTH AND IGG LEVELS IN KIDNEY TRANSPLANT RECIPIENTS: 1873 (2010) (1)
Pediatric renal transplantation. (1994) (1)
Trends in serum creatinine levels and transplant year. (2005) (1)
Effect of sex on kidney transplants. (1987) (1)
Clinical application of four tumor markers in monitoring of cancer patients (1989) (1)
Nomenclature for factors of the HLA system, 2002. (2002) (1)
Auto-anti-idiotypic antibody against DR antibody (1982) (1)
Tissue Typing, Crossmatching and the Allocation of Cadaveric Kidney Transplants (2001) (1)
ANTIBODIES TO B-LYMPHOCYTES IN RENAL TRANSPLANTATION (1977) (1)
How should cadaver-donor kidneys be allocated in the United States? (1995) (1)
The complexity of HLA-DP region (DPB1, DPB2, DPA1, DPA2) as defined by RFLP (1988) (1)
The development of a lymphocyte population with suppressor phenotype after successful liver transplantation. (1989) (1)
The 1993 cell typings of the International Cell Exchange. (1993) (1)
ASHI conference, Vancouver, Canada, October 10th, 1998 (1999) (1)
HL-A heterozygosity as a genetic marker of long-term survival. (1974) (1)
Heart Transplants—The Immunologic Questions (1968) (1)
Leucocyte antigens in man: A comparison of lymphocytotoxic and agglutination assays for their detection (1966) (1)
Reduction of error rates in the microlymphocytotoxicity test. (2008) (1)
99. Studies on the relationship of bronchial hyperreactivity to methacholine and HLA haplotypes in asthmatic families (1978) (1)
Molecular characterization of HLA-A*6803 (1996) (1)
International cell exchange-correlation of serologic equivalents to rare and novel alleles identified in cells contributed to the 13th IHWS (2002) (1)
IN DEFENSE OF DELIBERATE BLOOD TRANSFUSIONS (1980) (1)
LOW-DOSE IMMUNOSUPPRESSIVE THERAPY IN KIDNEY TRANSPLANTATION (1982) (1)
Standardization of HLA through an international cell exchange. (1987) (1)
DR phenotype matching and transfusion in patients treated with cyclosporine. (1988) (1)
Comparison of HLA matching protocols to maximize the number of compatible kidney recipients in small Asian pools. (1994) (1)
Immunobiology of Allograft Human Leukocyte Antigens in the New Microenvironment (2015) (1)
Suppression of Allo-HLA IgG Secreted By Long-Lived Bmem Cells In Vitro By a HLA-E mAb Versus IVIg.: Abstract# D2326 (2014) (1)
72-P Pre-transplant HLA-DSA that persist post-transplant predict increased risk of antibody-mediated rejection and graft loss in renal transplantation (2011) (1)
Longmire Lecture: My 50 Years at the University of California, Los Angeles (2000) (1)
Clinical use of the tetrazolium test for evaluation of potential cadaveric donors for renal homotransplantation. (1968) (1)
Early evaluation of Ia monoclonal antibodies in prolonging non-human primate skin allograft survival. (1981) (1)
78-P: HLA class I epitopes I: Detection by eluted antibodies from recombinant single-antigen cell lines (2006) (1)
A study of HLA and DRw antigens in recurrent herpes progenitalis (HSV-2) infection severe (1982) (1)
Presensitization patterns in renal allograft recipients—A correlation with graft outcome (1979) (1)
Effect of primary diseases. (2003) (1)
HLA identical kidney transplant recipients who reject grafts have high incidences of antibodies to endothelial cells and MICA (2005) (1)
Early graft function. (1991) (1)
Production of anti-W24 xenoantisera in rabbits. (1975) (1)
The UNOS Scientific Renal Transplant Registry. United Network for Organ Sharing. (1994) (1)
Automated reading of the microcytotoxicity test. (1989) (1)
The effect of individual HLA antigens on graft survival rates in kidney transplant patients. (1984) (1)
Joint report of the fourth Japan HLA workshop: B cell workshop 1. (2008) (1)
When Is the Best Time to Screen for De Novo Donor Specific Anti-HLA Antibodies (DSA) in Low-Risk Renal Transplant Recipients?: 2231 (2012) (1)
HLA in paternity testing. (1978) (1)
HLA-DP polymorphism in blacks (1994) (1)
Selective Depletion of Complement-Binding Anti-HLA Antibodies Following BLyS Neutralization with Belimumab.: Abstract# B3028 (2014) (1)
HLA frequencies among rejectors and low responders to kidney allografts. (1976) (1)
Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants. (2008) (1)
61-P: HLA class I epitopes: 103 total epitopes to-date including the C locus (2007) (1)
KIDNEY TRANSPLANT REGRAFT RESULTS IMPROVED BY PEROPERATIVE BLOOD TRANSFUSIONS (1986) (1)
C4D BINDING CORRELATED WITH STRONG HLA ANTIBODIES INVOLVED IN GRAFT FAILURES (2008) (1)
ASSOCIATION OF DONOR-SPECIFIC HLA ANTIBODY WITH ACUTE REJECTION IN LIVING-DONOR LIVER TRANSPLANTATION: A POSSIBLE EVIDENCE OF HUMORAL SENSITIZATION: 3230 (2010) (1)
Mica and micb antibodies in patients who rejected kidney transplants (2003) (1)
Cyclosporine A and histocompatibility in kidney transplantation. (1988) (1)
42-P: Antibodies against HLA class I/II and MICA in rejection and at graft failure (2006) (1)
Serology of HLA. (1981) (1)
Donor-specific serum transfusion prolongs survival of orthotopic liver transplantation in the rat. (1989) (1)
HLA Antibodies Developed in the First Year Post Transplant Are Predictive of Renal Allograft Failure. (2009) (1)
A gold medal for organ donors and donor families. (1998) (1)
Red-cell crossmatching for heart transplants. (1991) (1)
HL-A Antigens in Solid Tumors 1 (2006) (1)
Acute liver allograft antibody-mediated rejection (2018) (1)
SERIAL TEN YEAR FOLLOW-UP OF HLA AND MICA ANTIBODY PRODUCTION BEFORE KIDNEY GRAFT FAILURE (2004) (1)
History of some currently utilized procedures in transplantation. (1999) (1)
Blood transfusion and transplantation (1982) (1)
Study of Factors Influencing Induced Tolerance to Skin (1957) (0)
97-P DSA vs. NDSA reactions against disulfide bond-reduced HLA class II DQ antigens (2011) (0)
RFLP Standardization Report for DR Alpha/SstI (1989) (0)
Safe preservation of human cadaver kidneys by cold storage up to 60 hours (1984) (0)
60-OR: A Novel HLA Class I Single Antigen Bead Preparation Eliminates False Positive Reactions Attributed to Natural Antibodies – in the Sera of Post Transplant Patients (2010) (0)
Sources of data: A literature search was performed using PubMed on the topics of 'antibody monitoring', 'autoantibody and allograft dysfunction' and 'prevention and treatment of antibody-mediated rejection (AMR)'. (2013) (0)
Presensitization patterns in renal allograft recipients-A correlation with graft outcome. (1979) (0)
Serologic detection of Dw12 antibody (1982) (0)
Atorvastatin Use Is Associated With Improved Post-De Novo Anti-HLA DSA Allograft Survival.: Abstract# 2890 (2014) (0)
SIXTEEN KIDNEY TRANSPLANT PATIENTS SURVIVING FOR ALMOST 2 YEARS WITH NO MAINTENANCE IMMUNOSUPPRESSION OR STEROIDS ALONE: 777 (2010) (0)
Anti-mucin antibodies in kidney transplantation (1988) (0)
AbstractRefinement of the cFDA micro platelet cytotoxicity test for the detection of platelet specific antigens (1991) (0)
77-P: HIGHER RISK OF KIDNEY GRAFT FAILURE AFTER REJECTION IN THE PRESENCE OF ANTIBODIES AGAINST ANGIOTENSIN II TYPE 1 RECEPTOR (AT1R) (2012) (0)
8.1-02 Epitope matching for renal transplantation, a molecular approach (1989) (0)
DOES MICA HAVE INFLUENCE ON ACUTE REJECTION IN KIDNEY TRANSPLANTATION? (2006) (0)
HLA DR typing by polymerase chain reaction in Terasaki trays. (1995) (0)
RFLP Standardization Report for DP Alpha/SstI (1989) (0)
A monoclonal antibody 1A6 to T‐cell recognizes a common antigen expressed on lymphocytes from normal and leukemic patients, and inhibits nk cell activity (1989) (0)
10.1-03 Evaluation of the first 100 kidneys shared by the unos point system (1989) (0)
70: De Novo Formed Donor-Specific Antibodies Adversely Affect Patient Survival after Cardiac Transplantation (2010) (0)
8.1-11 Platelet crossmatching in kidney transplantation (1989) (0)
Brief Definitive Report B-lymphocyte Alloantigens in Caucasians* (0)
Donor specific blood transfusions in HLA-D disparate related allografts (1980) (0)
Reductions in Immunosuppression Are Associated With IgM-to-IgG DSA Isotype Switch and Risk of Post-DSA Allograft Loss.: Abstract# 2214 (2014) (0)
23-P: HLA Antibody Screening With Intact Class I Single Antigen Beads (2010) (0)
A NON-ALLOGENEIC STIMULUS TRIGGERS THE PRODUCTION OF DE NOVO HLA AND MICA ANTIBODIES.: 727 (2008) (0)
Influence of Recipient Age On Long-Term Simultaneous Pancreas Kidney Transplants: An Analysis of UNOS Data.: Abstract# B1276 (2014) (0)
Effect of homologous kidney antibody upon metabolism of kidney cells. Abstr. (1962) (0)
Courage and character, leaders and legends: an interview with Paul I. Terasaki, PhD. Interview by Linda Ohler. (2012) (0)
Use of Monoclonal Antibodies to Sialylated Lewisx and Sialylated Lewis 3 for Serological Tests of Cancer 1 (2006) (0)
P630 - Characterization of an elusive HLA-A*6803 allele (1996) (0)
INDUCTION IMMUNOSUPPRESSION IMPROVES GRAFT SURVIVAL IN ORGAN TRANSPLANTATION: A REPORT OF 15 YEARS UNOS REGISTRY DATA: 809 (2010) (0)
Stratifi cation of Immunologic Risk in Renal Transplant Recipients (2017) (0)
A Microculture Method for Production of Monoclonal Antibodies (1984) (0)
76-P Only IgG1 antibodies against HLA and MICA are significantly associated with renal graft failure: Results of a four-year cohort study (2011) (0)
Incidence and Impact of Anti-HLA-DP-Antibodies in Renal Transplantation.: Abstract# 724 (2014) (0)
Selection of organ donors. (1969) (0)
24 HIGH MFI PREFORMED CLASS II DONOR SPECIFIC ANTIBODIES ACCELERATE FIBROSIS AND INCREASE MORTALITY AFTER LIVER TRANSPLANT IN HCV-INFECTED PATIENTS (2013) (0)
Nomenclature for factors of the HLA system, 2000. (2001) (0)
Hematologic Diseases (2018) (0)
Atorvastatin Use Is Associated With Improved Post-De Novo Anti- HLA DSA Allograft Survival. M. Everly,1 (2017) (0)
1.3-04 Serologic detection of DQA specificities (1989) (0)
Antigen Society #5 Report (B5, B51, Bw52, B18, B35, Bw53) (1989) (0)
RECIPIENT SYMPTOMATIC PERIPHERAL VASCULAR DISEASE HAS A DELETERIOUS EFFECT ON CADAVER DONOR RENAL TRANSPLANTS (1998) (0)
RFLP Standardization Report for DQ Alpha/SstI (1989) (0)
Clinical application of monoclonal antibody for cancer therapy (1985) (0)
Association Between Post-Transplant HLA Antibodies, Proteinuria, and Glomerular Filtration Rate in Adult Renal Transplant Recipients: 1966 (2012) (0)
Serotyping for homotransplantation. 28. Sib-pair assay for nonHL-A antigens. (1969) (0)
A new simplified micro CTL test (1994) (0)
Poster42-P: No occurrence of de novo donor-specific HLA antibodies in patients with early steroid withdrawal in a 5-year prospective study (2008) (0)
DRw6 and 8WDRw6 (1982) (0)
Southern Blot Analysis of Rheumatoid Arthritis (1989) (0)
HLA MISMATCHES AND PRA IN KIDNEY RE- TRANSPLANTS: 2154 (2008) (0)
Batonnet a humer (1987) (0)
Serologic typing of f2 mice for homograft compatibility. Abstr. (1963) (0)
Multiple sclerosis intheOrkneyandShetland Islands V:Theeffect on viral titres ofhistocompatibili ty determinants (1980) (0)
A micro cytotoxicity test for cell mediated killing (1992) (0)
and the Allocation of Cadaveric Kidney Transplants (2001) (0)
Antibodies against class I molecules and graft survival (1992) (0)
RFLP Standardization Report for C4/SstI (1989) (0)
INCREASED INCIDENCE OF W27 IN JUVENILE RHEUMATOID ARTHRITIS (1974) (0)
5.4-07 Oligonucleotide typing for DR beta and DQ beta (1989) (0)
International HLA DNA exchange-summary of first year results (1994) (0)
Novel Biomarker Combo Is Better Than Donor Specific Antibody in Predicting Long-Term Renal Allograft Outcome.: Abstract# A2988 (2014) (0)
Conformational HLA epitopes identified by computer sorting (1992) (0)
3.1-01 Immunoglobulin binding by HLA molecules (1989) (0)
NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1994 (1994) (0)
RFLP Standardization Report for 210H/SstI (1989) (0)
PROSPECTIVE TESTS ON THE PREDICTIVE VALUE OF ANTI HLA AND MICA ANTIBODIES: 2152 (2008) (0)
Permissible HLA mismatches for kidney transplants (1994) (0)
RFLP Standardization Report for BF/SstI (1989) (0)
1.1-03 Antisera to HLA epitopes (1989) (0)
Identification of Risk Factors Associated with the Induction/Increase of Donor Specific HLA Antibodies And/Or Islet Specific Autoantibodies after Islet Transplantation: 1890 (2012) (0)
HLA matching by amino acid/positions in double and triple combinations. (2006) (0)
Association of Anti-HLA Antibody with Operational Tolerance in Pediatric Living-Donor Liver Transplantation: A Possible Evidence of Humoral Sensitization: 1531 (2012) (0)
OP-073 HLA identical Kidney Transplant Recipients Who Reject Grafts Have High Incidences of Antibodies to Endothelial cells and MICA(OP) (2006) (0)
Effect of Water-soluble Adjuvantson in Vitro Lymphocyte 1 (1975) (0)
Interview with Dr Paul Terasaki. (2003) (0)
48-OR: A 13 year study to investigate production of de novo DSA on graft survival after heart transplantation (2011) (0)
Three year follow-up on prospective chronic rejection study (2005) (0)
46-P: Majority of non-donor specific DR antibodies shares epitopes with mismatched donor antigens in renal transplant recipients (2006) (0)
Higher Risk of Kidney Graft Failure in Patients with Rejection Episodes in the Presence of Anti-Angiotensin II Type 1 Receptor Antibodies: 2168 (2012) (0)
Specialty Conference Cardiac Transplantation Selection , Immunosuppression , and Survival (0)
1004-LB: The role of de novo DQ donor specific antibodies (DSA), IgG subclasses and C1q in kidney transplant outcome (2013) (0)
C4D BINDING CORRELATED WITH STRONG HLA ANTIBODIES CAN CAUSE GRAFT FAILURE: 2894 (2010) (0)
56-P: Fliourescence intensity and titer of HLA antibodies paralleling serum creatinine increase post transplantation (2006) (0)
RFLP Standardization Report for DR Beta/EcoRV (1989) (0)
Changes in Successive Measures of De Novo DSA Intensity Predict Development of Renal Allograft Dysfunction.: Abstract# B868 (2014) (0)
RFLP Standardization Report for C2/SstI (1989) (0)
A comparison of sensitive crossmatch techniques for renal transplant patients (1988) (0)
HLA matching and organ transplantation (1991) (0)
Mycophenolate Acid Reduce Donor Specific HLA Antibody Strength in Kidney Transplant Recipients: 2314 (2012) (0)
Increasing kidney supply as the best solution to the allocation problem (1998) (0)
Conserved sequence motifs in the alpha helices of the serological variants HLA-B “DT” and HLA-B “NM5” (1994) (0)
HLA class I epitopes defined by murine monoclonal antibodies adim (0)
Effects of blood transfusions on renal transplants: considering exclusive blood products and donor relationship. (1983) (0)
UNRELATED DONORS YIELD HIGHER GRAFT SURVIVAL RATES THAN PARENTAL DONORS IN PATIENTS WITH IDDM, PC, AND FGS. (2004) (0)
Restriction Fragment Length Polymorphism in Serologically Defined DR5: The Difference Between DRwll and DRw12 (1989) (0)
A comparison of class ii hla serotyping and molecular typing in predicting grade ii iv acute graft versus host disease in unrelated donor marrow transplants (1992) (0)
Anomalous Prolonged Allograft Survival after Deliberate Immunization Against Graft-Specific Alloantigens (2019) (0)
4. HLA matching and organ transplantation (1991) (0)
Monoclonal antibodies produced against a human lung carcinoma. Abstr. (1981) (0)
1996 Medawar Prize Lecture. (1997) (0)
High Mean Fluorescence Intensity DSA and IgG3 Subclass DSA after Liver Transplantation Decrease Patient and Graft Survival: 1343 (2012) (0)
ISLET CELL TRANSPLANTS FAIL DUE TO DONOR SPECIFIC ANTIBODIES: 3364 (2010) (0)
68-P: HLA class II DQ antibody production before kidney graft failure (2007) (0)
Evaluation of Pancreatic Graft Function Using 11C-Methionine Positron Emission Tomography in Pancreas Transplantation. K. Otsuki,1 (2017) (0)
RFLP Standardization Report for Class I/SstI (1989) (0)
Structural Limitations to the Mimetic HLA Epitope Hypothesis (2009) (0)
Post Transplant donor specific antibodies increase the predictability of Chronic rejection (2009) (0)
RFLP Standardization Report for DQ Beta/EcoRV (1989) (0)
Effect of amino acid mismatch in the UNOS 2007 dataset. (2007) (0)
Serologically defined B-lymphocyte antigen expression in patients with malignant melanoma. (1979) (0)
Are the effects of prolonged cold ischemia a barrier to long-distance transportation of living donor kidneys? (2007) (0)
Cancer-associated quantitative differences in antigen levels of sialosyl Lewisx in stool from patients with colorectal carcinomas (1994) (0)
Influence of antimucin antibody in kidney transplantation. (1989) (0)
Humoral Responses to Collagen-V and Vimentin Are Associated with Renal Graft Failure: 2192 (2012) (0)
Novel biomarker combination predicts long-term allograft outcome. (2013) (0)
Actual 5-Year Post-De Novo DSA Outcomes in Low Risk Primary Kidney Transplant Recipients.: Abstract# B856 (2014) (0)
185-P High frequency of anti HLA-DQ7 (DQB1*0301) antibodies found in healthy non-alloimmunized males (2011) (0)
6.2-07 DP subtype association in cancer patients (1989) (0)
Association of B cold cytotoxins and anti-F (ab')2 antibodies with inhibition of mixed lymphocyte culture. (1983) (0)
Living donor chains for kidney transplants. (2009) (0)
Nomenclature for factors of the HLA system-1977. (1978) (0)
Effect of Water-soluble Adjuvants on in Vitro Lymphocyte (2006) (0)
Loss of HLA-C locus specificities from stored lymphocytes and de novo synthesis following incubation at 37 degrees C. (1981) (0)
O616 – Improved direct sequencing system for accurate detection of heterozygosity in HLA-A, B and C loci (1996) (0)
Hemolytic plaque formation to allogeneic human type A and B red cells. (2008) (0)
Predictability of DTT cross match (1988) (0)
46-OR: RESULTS FROM THE CURRENT 16TH INTERNATIONAL HISTOCOMPATIBILITY AND IMMUNOGENETICS WORKSHOP STUDY ON NATURAL HISTORY OF POST-TRANSPLANT HLA ANTIBODY DEVELOPMENT (2012) (0)
Letter: HL-A W29 and subacute sclerosing panencephalitis. (1975) (0)
Risk factors in human renal transplantation. (1974) (0)
1024-LB: HLA DQA and DQB epitopes: Determined by alloantibodies adsorbed and eluted from recombinant HLA DQ single antigen cell lines and the antibodies’ reaction patterns with HLA DQ single antigen beads (2013) (0)
The origins of collaborative organ salvaging and sharing: Los Angeles, 1967. (2007) (0)
INDEFINITE SURVIVAL OF ISOLATED PANCREATIC ISLETS IN RATS RENDERED IMMUNOLOGICALLY UNRESPONSIVE TO RENAL ALLOGRAFTS (1982) (0)
Capping of Granulocyte Membrane Antigens1 (2008) (0)
Micro SSP-PCR for detection of HLA class II DRB genes (1994) (0)
Reduction of the center by HLA matching (1993) (0)
47-P: New evidence that de novo antibodies produced after transplantation cause chronic graft failure (2007) (0)
Complement and Immune Deficiencies (1985) (0)
Identifying Surrogate Endpoints for DSA Treatment Trials Based on Data from a 10-Year Longitudinal Study of Primary Renal Transplant Recipients.: Abstract# D3074 (2014) (0)
30-P: Normalization and analysis of luminex-based HLA antibody detection assays (2009) (0)
79-P Determination of a single antigen bead MFI cutoff for de novo DSA based on 10 year outcomes of a longitudinally studied renal transplant population (2011) (0)
A NEW PROTOCOL OF CLONAL DELETION AND ALLOGENEIC STEM CELL TRANSPLANTATION WITH NO POSTTRANSPLANT IMMUNOSUPPRESSION IN LIVING RELATED DONOR RENAL TRANSPLANTATION: 192 (2008) (0)
ANTIBODIESS TO HLA ELICITED BY PEPTIDES FROM OTHER MOLECULES: 726 (2008) (0)
RFLP Standardization Report for DP Beta/EcoRV (1989) (0)
50-OR: Defining incidence of and risk from DSA based on a prospective 10 year longitudinal study of consecutive renal transplant recipients (2011) (0)
pitopes of human leukocyte antigen class I antibodies found in sera of normal ealthy males and cord blood (0)
Natural History and Temporal Relationship Between de Novo DSA and Allograft Dysfunction Based on Consecutive Kidney Transplant Patients Followed for Over 5 Years: 1181 (2012) (0)
37-OR: Human neutrophil antigen (HNA)-specific antibodies are associated with renal allograft loss (2009) (0)
38-OR: The Combined Occurrence of IgG1+IgG3+IgG4 Subclasses in Post-Transplant Sera Was Found to Be Most Correlated With Failure of Kidney Transplants (2010) (0)
The History of HLA and Transplantation [Innovation in Transplant and Regenerative Medicine. The 13th Meeting of Hirosaki International Forum of Medical Science. Communication Center of Hirosaki University School of Medicine. September 9, 2011, Hirosaki, Japan] (2013) (0)
Limits for non-amplified sources of DNA (cellular and isolated DNA) by PCR-SSP (1994) (0)
Detection of hla antibodies in kidney transplant recipients (1991) (0)
1.3-05 Definition of DRB3 alleles by serology (1989) (0)
of Transfusion-Related Alloimmunization in Intensively (2016) (0)
58-P: Development of donor specific HLA antibodies is associated with graft failure (2007) (0)
Humoral responses to renal allografts are not always donor-specific (2005) (0)
SD new world workshop report. (1977) (0)
80-P: Intact-, not denatured, HLA class I specific antibodies are predictive of graft failure (2009) (0)
58-OR: Detection of MICA antibodies and epitope analysis using Luminex MICA single antigen beads (2006) (0)
Instability in Canadian Medicare: the case of dialysis delivery. (1996) (0)
OR51 : ANTIBODIES AGAINST PROTEASE-ACTIVATED RECEPTORS (PAR) AFTER IMMUNOSUPPRESSION WITHDRAWAL IN PEDIATRIC LIVING-DONOR LIVER TRANSPLANT (2014) (0)
Specialty Conference Familial Mediterranean Fever Recent Advances in Pathogenesis and Management (2005) (0)
Statistical Modeling for Kidney Transplant Data (1987) (0)
Sharing of HLA antigens in couples with unexplained recurrent pregnancy loss is irrelevant to the condition (1989) (0)
HLA FOR ORGAN TRANSPLANTS (1999) (0)
EFFECT OF HLA MISMATCH IN AFRICAN-AMERICANS 1 (2010) (0)
Antinuclear Antibodies in Psychiatric Patients treated with Psychotropic Drugs (1983) (0)
M-ISY-3 Monitoring Transplant Patients with Antibodies (2004) (0)
HLA ANTIBODIES CAN BE DETECTED IN KIDNEY ALLOGRAFT BIOPSIES AND NEPHRECTOMY TISSUE EVEN WHEN NOT PRESENT IN SERUM: 822 (2010) (0)
AbstractAnalysis of the tenth workshop RFLP data on class II (1988) (0)
Relationship Between BK Viremia, De Novo Anti-HLA DSA, and Outcomes in Renal Transplant Recipients.: Abstract# 728 (2014) (0)
Transplant Success Stories 1993 (1993) (0)
Tolerance of skin grafts produced by various adutl cells, soluble extracts, and embryonic cells. (1959) (0)
217-P: Non-alloimmunized (natural) HLA antibodies are present in cord blood (2009) (0)
The greater influence of HLA matching in younger kidney allograft recipients (1988) (0)
The UNOS Scientific Renal Transplant Registry. (1989) (0)
Attempts to induce homograft tolerance by treatment of adult animals and increased antibody formation by cortisone treatment of neonatals. Abstr. (1961) (0)
BORTEZOMIB EFFECTIVENESS IN 69 PATIENTS TREATED IN 29 CENTERS WORLDWIDE: 1046 (2010) (0)
Detection of monoclonal antibodies for tumor diagnosis with the use of inhibition of micro-enzyme-linked immunosorbent assay. (1985) (0)
- Males: Pattern of HLA-Ia Reactivity of Anti Antibodies to HLA-E in Nonalloimmunized (2010) (0)
Relative effect of HLA matching and cold ischemia time (1995) (0)
Rising Incidence of De Novo Anti-HLA DSA in African American Renal Transplant Recipients Over a Decade.: Abstract# A237 (2014) (0)
8.1-14 An unofficial examination of six-antigen match transplants (1989) (0)
Is DNA typing necessary for clinical kidney transplants (1992) (0)
Antibodies against MICA are found in addition to anti HLA antibodies in patients who reject a transplant (2004) (0)
CLONAL DELETION WITH BORTEZOMIB PERMITS RENAL TRANSPLANT WITH LOW-DOSE CORTICOSTEROIDS ALONE: 1053 (2010) (0)
John David McClelland (2003) (0)
Serotyping for homotransplantation. XXIV. Heart transplantation. (1970) (0)
Announcements (1979) (0)
Hyperlipidemia following liver transplantation: Efficacy, safety, and immunomodulation with pravastatin (1995) (0)
HLA typing in the non-X-linked muscular dystrophies (1979) (0)
10-OR A more accurate assessment of efficacy of antibody reduction by plasmapheresis or bortezomib is revealed by testing sera in dilutions (2011) (0)
Presence of anti Lewis antibodies in the sera of two patients with chronic rejection of the heart (2003) (0)
HLA matching assessed from early graft function. (1987) (0)
50-P: Mica alloantibodies in the serum of renal recipients correlated with loss of function of kidney allografts (2006) (0)
Improved Long-Term Graft Survival After Deceased Donor Kidney Transplantation in the United States From 1988 to 2007.: Abstract# C1822 (2014) (0)
B-cell antibodies in patients with rejecting transplants. (1978) (0)

This paper list is powered by the following services:

Other Resources About Paul Terasaki

en.wikipedia.org

What Schools Are Affiliated With Paul Terasaki?

Paul Terasaki is affiliated with the following schools:

Paul Terasaki's Academic­Influence.com Rankings